organization · Reporting owner

Andreessen Horowitz LSV Fund I-Q, L.P.

Disclosed activity across 4 companies

Tapewire entity: 69703
SEC CIK: 0001772407

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
Coinbase Global, Inc.COIN · Entity 480	10% owner	May 21, 2021	May 25, 2021
Navan, Inc.NAVN · Entity 3707	10% owner	January 07, 2026	January 09, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Coinbase Global, Inc.

Report date May 21, 2021 · Filed May 25, 2021

Jointly reported with Andreessen Horowitz LSV Fund I, L.P., Andreessen Horowitz LSV Fund I-B, L.P., AH Equity Partners LSV I, L.L.C., AH Equity Partners III (Parallel), L.L.C., a16z Capital Management, L.L.C., HOROWITZ BENJAMIN A

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	IndirectBy Andreessen Horowitz Fund III, L.P.	103,075	Last balance in matching sequence After 2021-05-21 transaction · row 6 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 3 source rows Row 1 · 2021-05-21 · Conversion · Acquired 5,220,839 · Balance 5,220,839 F1: Represents the conversion of 5,220,839 shares of Class B Common Stock held of record by Andreessen Horowitz Fund III, L.P. into Class A Common Stock. F2: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F3: These securities are held by Andreessen Horowitz Fund III, L.P., for itself and as nominee for Andreessen Horowitz Fund III-A, L.P., Andreessen Horowitz Fund III-B, L.P., and Andreessen Horowitz Fund III-Q, L.P. (collectively, the "AH Fund III Entities"). AH Equity Partners III, L.L.C. ("AH EP III"), the general partner of the AH Fund III Entities, has sole voting and dispositive power with regard to the securities held by the AH Fund III Entities. Marc Andreessen and Ben Horowitz are the managing members of AH EP III and share voting and dispositive power with respect to the shares held by the AH Fund III Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Fund III Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Row 5 · 2021-05-21 · Other · Acquired 425,185 · Balance 5,646,024 F9: On May 21, 2021, a16z Seed distributed, for no consideration, 425,185 shares of the Issuer's Class A Common Stock (the "a16z Seed Shares") to the AH Fund III Entities, representing each such member's pro rata interest in such a16z Seed Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended. F3: These securities are held by Andreessen Horowitz Fund III, L.P., for itself and as nominee for Andreessen Horowitz Fund III-A, L.P., Andreessen Horowitz Fund III-B, L.P., and Andreessen Horowitz Fund III-Q, L.P. (collectively, the "AH Fund III Entities"). AH Equity Partners III, L.L.C. ("AH EP III"), the general partner of the AH Fund III Entities, has sole voting and dispositive power with regard to the securities held by the AH Fund III Entities. Marc Andreessen and Ben Horowitz are the managing members of AH EP III and share voting and dispositive power with respect to the shares held by the AH Fund III Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Fund III Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Row 6 · 2021-05-21 · Other · Disposed 5,542,949 · Balance 103,075 F10: On May 21, 2021, the AH Fund III Entities distributed, for no consideration, 5,542,949 shares of the Issuer's Class A Common Stock (the "AH Fund III Shares") to their limited partners and to AH EP III, the general partner of the AH Fund III Entities, representing each such partner's pro rata interest in such AH Fund III Shares. On the same date, AH EP III distributed, for no consideration, the AH Fund III Shares it received in the distribution by the AH Fund III Entities to its members, representing each such member's pro rata interest in such AH Fund III Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended. F3: These securities are held by Andreessen Horowitz Fund III, L.P., for itself and as nominee for Andreessen Horowitz Fund III-A, L.P., Andreessen Horowitz Fund III-B, L.P., and Andreessen Horowitz Fund III-Q, L.P. (collectively, the "AH Fund III Entities"). AH Equity Partners III, L.L.C. ("AH EP III"), the general partner of the AH Fund III Entities, has sole voting and dispositive power with regard to the securities held by the AH Fund III Entities. Marc Andreessen and Ben Horowitz are the managing members of AH EP III and share voting and dispositive power with respect to the shares held by the AH Fund III Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Fund III Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.
Class A Common StockSEC Table I · non-derivative	IndirectBy AH Parallel Fund III, L.P.	0	Last balance in matching sequence After 2021-05-21 transaction · row 7 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 2 · 2021-05-21 · Conversion · Acquired 454,334 · Balance 454,334 F4: Represents the conversion of 454,334 shares of Class B Common Stock held of record by AH Parallel Fund III, L.P. into Class A Common Stock. F2: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F5: These securities are held by AH Parallel Fund III, L.P., for itself and as nominee for AH Parallel Fund III-A, L.P., AH Parallel Fund III-B, L.P., and AH Parallel Fund III-Q, L.P. (collectively, the "AH Parallel Fund III Entities"). AH Equity Partners III (Parallel), L.L.C. ("AH EP III Parallel"), the general partner of the AH Parallel Fund III Entities, has sole voting and dispositive power with regard to the shares held by the AH Parallel Fund III Entities. Marc Andreessen and Ben Horowitz are the managing members of AH EP III Parallel and share voting and dispositive power with respect to the shares held by the AH Parallel Fund III Entities. F6: (Continued from Footnote 5) Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Parallel Fund III Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Row 7 · 2021-05-21 · Other · Disposed 454,334 · Balance 0 F11: On May 21, 2021, the AH Parallel Fund III Entities distributed, for no consideration, 454,334 shares of the Issuer's Class A Common Stock (the "AH Parallel Fund III Shares") to their limited partners and to AH EP III Parallel, the general partner of the AH Parallel Fund III Entities, representing each such partner's pro rata interest in such AH Parallel Fund III Shares. On the same date, AH EP III Parallel distributed, for no consideration, the AH Parallel Fund III Shares it received in the distribution by the AH Parallel Fund III Entities to its members, representing each such member's pro rata interest in such AH Parallel Fund III Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended. F5: These securities are held by AH Parallel Fund III, L.P., for itself and as nominee for AH Parallel Fund III-A, L.P., AH Parallel Fund III-B, L.P., and AH Parallel Fund III-Q, L.P. (collectively, the "AH Parallel Fund III Entities"). AH Equity Partners III (Parallel), L.L.C. ("AH EP III Parallel"), the general partner of the AH Parallel Fund III Entities, has sole voting and dispositive power with regard to the shares held by the AH Parallel Fund III Entities. Marc Andreessen and Ben Horowitz are the managing members of AH EP III Parallel and share voting and dispositive power with respect to the shares held by the AH Parallel Fund III Entities. F6: (Continued from Footnote 5) Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Parallel Fund III Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.
Class A Common StockSEC Table I · non-derivative	IndirectBy a16z Seed-III, LLC	0	Last balance in matching sequence After 2021-05-21 transaction · row 4 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 2 source rows Row 3 · 2021-05-21 · Conversion · Acquired 322,110 · Balance 425,185 F7: Represents the conversion of 322,110 shares of Class B Common Stock held of record by a16z Seed-III, LLC ("a16z Seed") into Class A Common Stock. F2: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F8: These securities are held of record by a16z Seed. The securities held directly by a16z Seed are indirectly held by the AH Fund III Entities, the members of a16z Seed. AH EP III, the general partner of the AH Fund III Entities, has sole voting and dispositive power with regard to the shares held by a16z Seed. Marc Andreessen and Ben Horowitz are the managing members of AH EP III and share voting and dispositive power with respect to the shares held by a16z Seed. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by a16z Seed and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Row 4 · 2021-05-21 · Other · Disposed 425,185 · Balance 0 F9: On May 21, 2021, a16z Seed distributed, for no consideration, 425,185 shares of the Issuer's Class A Common Stock (the "a16z Seed Shares") to the AH Fund III Entities, representing each such member's pro rata interest in such a16z Seed Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended. F8: These securities are held of record by a16z Seed. The securities held directly by a16z Seed are indirectly held by the AH Fund III Entities, the members of a16z Seed. AH EP III, the general partner of the AH Fund III Entities, has sole voting and dispositive power with regard to the shares held by a16z Seed. Marc Andreessen and Ben Horowitz are the managing members of AH EP III and share voting and dispositive power with respect to the shares held by a16z Seed. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by a16z Seed and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.
Class A Common StockSEC Table I · non-derivative	IndirectBy Andreessen Horowitz LSV Fund I, L.P.	2,263,232	Reported balance After 2021-05-21 transaction · row 8 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 8 · 2021-05-21 · Other · Disposed 1,154,711 · Balance 2,263,232 F12: On May 21, 2021, the AH LSV Fund I Entities (as defined below) distributed, for no consideration, 1,154,711 shares of the Issuer's Class A Common Stock (the "AH LSV Fund I Shares") to their limited partners and to AH EP LSV I (as defined below), the general partner of the AH LSV Fund I Entities, representing each such partner's pro rata interest in such AH LSV Fund I Shares. On the same date, AH EP LSV I distributed, for no consideration, the AH LSV Fund I Shares it received in the distribution by the AH LSV Fund I Entities to its members, representing each such member's pro rata interest in such AH LSV Fund I Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended. F13: These securities are held by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the "AH LSV Fund I Entities"). AH Equity Partners LSV I, L.L.C. ("AH EP LSV I"), the general partner of the AH LSV Fund I Entities, has sole voting and dispositive power with regard to the shares held by the AH LSV Fund I Entities. Marc Andreessen and Ben Horowitz are the managing members of AH EP LSV I and share voting and dispositive power with respect to the shares held by the AH LSV Fund I Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.
Class A Common StockSEC Table I · non-derivative	IndirectBy AH Capital Management, L.L.C.	0	Last balance in matching sequence After 2021-05-24 transaction · row 17 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 8 source rows Row 9 · 2021-05-21 · Other · Acquired 17,473 · Balance 17,473 F14: Represents shares received by AH Capital Management, L.L.C. pursuant to pro rata distributions by AH EP III, AH EP III Parallel and AH EP LSV I, for no consideration, of shares of the Issuer's Class A Common Stock to their respective members. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended. F15: The securities are held of record by AH Capital Management, L.L.C. The members of AH Capital Management, L.L.C. are Marc Andreessen and Ben Horowitz, who share voting and dispositive power with respect to the shares held by AH Capital Management, L.L.C. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by AH Capital Management, L.L.C. and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Row 11 · 2021-05-24 · Sale · Disposed 873 · Balance 16,600 F18: Represents the weighted average sale price. The lowest price at which shares were sold was $224.33 and the highest price at which shares were sold was $225.32. The Reporting Persons undertake to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or the Issuer's stockholders, full information regarding the total number of shares sold at each separate price within the ranges set forth in footnotes (18) through (23) to this Form 4. F15: The securities are held of record by AH Capital Management, L.L.C. The members of AH Capital Management, L.L.C. are Marc Andreessen and Ben Horowitz, who share voting and dispositive power with respect to the shares held by AH Capital Management, L.L.C. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by AH Capital Management, L.L.C. and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Row 12 · 2021-05-24 · Sale · Disposed 7,700 · Balance 8,900 F19: Represents the weighted average sale price. The lowest price at which shares were sold was $225.34 and the highest price at which shares were sold was $226.335. F15: The securities are held of record by AH Capital Management, L.L.C. The members of AH Capital Management, L.L.C. are Marc Andreessen and Ben Horowitz, who share voting and dispositive power with respect to the shares held by AH Capital Management, L.L.C. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by AH Capital Management, L.L.C. and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Row 13 · 2021-05-24 · Sale · Disposed 5,799 · Balance 3,101 F20: Represents the weighted average sale price. The lowest price at which shares were sold was $226.34 and the highest price at which shares were sold was $227.30. F15: The securities are held of record by AH Capital Management, L.L.C. The members of AH Capital Management, L.L.C. are Marc Andreessen and Ben Horowitz, who share voting and dispositive power with respect to the shares held by AH Capital Management, L.L.C. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by AH Capital Management, L.L.C. and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Row 14 · 2021-05-24 · Sale · Disposed 1,201 · Balance 1,900 F21: Represents the weighted average sale price. The lowest price at which shares were sold was $227.35 and the highest price at which shares were sold was $228.05. F15: The securities are held of record by AH Capital Management, L.L.C. The members of AH Capital Management, L.L.C. are Marc Andreessen and Ben Horowitz, who share voting and dispositive power with respect to the shares held by AH Capital Management, L.L.C. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by AH Capital Management, L.L.C. and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Row 15 · 2021-05-24 · Sale · Disposed 1,600 · Balance 300 F22: Represents the weighted average sale price. The lowest price at which shares were sold was $228.49 and the highest price at which shares were sold was $229.46. F15: The securities are held of record by AH Capital Management, L.L.C. The members of AH Capital Management, L.L.C. are Marc Andreessen and Ben Horowitz, who share voting and dispositive power with respect to the shares held by AH Capital Management, L.L.C. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by AH Capital Management, L.L.C. and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Row 16 · 2021-05-24 · Sale · Disposed 200 · Balance 100 F23: Represents the weighted average sale price. The lowest price at which shares were sold was $229.67 and the highest price at which shares were sold was $229.79. F15: The securities are held of record by AH Capital Management, L.L.C. The members of AH Capital Management, L.L.C. are Marc Andreessen and Ben Horowitz, who share voting and dispositive power with respect to the shares held by AH Capital Management, L.L.C. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by AH Capital Management, L.L.C. and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Row 17 · 2021-05-24 · Sale · Disposed 100 · Balance 0 F15: The securities are held of record by AH Capital Management, L.L.C. The members of AH Capital Management, L.L.C. are Marc Andreessen and Ben Horowitz, who share voting and dispositive power with respect to the shares held by AH Capital Management, L.L.C. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by AH Capital Management, L.L.C. and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.
Class A Common StockSEC Table I · non-derivative	IndirectBy Trust	842,687	Reported balance After 2021-05-21 transaction · row 10 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 10 · 2021-05-21 · Other · Acquired 424,072 · Balance 842,687 F16: Represents shares received by the 1997 Horowitz Family Trust pursuant to pro rata distributions by the AH Fund III Entities, the AH Parallel Fund III Entities, the AH LSV Fund I Entities, AH EP III, AH EP III Parallel, and AH EP LSV I, for no consideration, of shares of the Issuer's Class A Common Stock to their respective partners or members, as applicable. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended. F17: These securities are held of record by a family trust for which Ben Horowitz is a trustee. Each of the Reporting Persons disclaims the existence of a "group" and, other than Ben Horowitz, disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.
Class B Common StockSEC Table II · derivative / convertible security	IndirectBy Andreessen Horowitz Fund III, L.P.	10,761,104	Reported balance After 2021-05-21 transaction · row 18 Instrument identity requires review; Table II rows are not merged. 1 source row Row 18 · 2021-05-21 · Conversion · Disposed 5,220,839 · Balance 10,761,104 F2: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F1: Represents the conversion of 5,220,839 shares of Class B Common Stock held of record by Andreessen Horowitz Fund III, L.P. into Class A Common Stock. F3: These securities are held by Andreessen Horowitz Fund III, L.P., for itself and as nominee for Andreessen Horowitz Fund III-A, L.P., Andreessen Horowitz Fund III-B, L.P., and Andreessen Horowitz Fund III-Q, L.P. (collectively, the "AH Fund III Entities"). AH Equity Partners III, L.L.C. ("AH EP III"), the general partner of the AH Fund III Entities, has sole voting and dispositive power with regard to the securities held by the AH Fund III Entities. Marc Andreessen and Ben Horowitz are the managing members of AH EP III and share voting and dispositive power with respect to the shares held by the AH Fund III Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Fund III Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.
Class B Common StockSEC Table II · derivative / convertible security	IndirectBy AH Parallel Fund III, L.P.	890,493	Reported balance After 2021-05-21 transaction · row 19 Instrument identity requires review; Table II rows are not merged. 1 source row Row 19 · 2021-05-21 · Conversion · Disposed 454,334 · Balance 890,493 F2: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F4: Represents the conversion of 454,334 shares of Class B Common Stock held of record by AH Parallel Fund III, L.P. into Class A Common Stock. F5: These securities are held by AH Parallel Fund III, L.P., for itself and as nominee for AH Parallel Fund III-A, L.P., AH Parallel Fund III-B, L.P., and AH Parallel Fund III-Q, L.P. (collectively, the "AH Parallel Fund III Entities"). AH Equity Partners III (Parallel), L.L.C. ("AH EP III Parallel"), the general partner of the AH Parallel Fund III Entities, has sole voting and dispositive power with regard to the shares held by the AH Parallel Fund III Entities. Marc Andreessen and Ben Horowitz are the managing members of AH EP III Parallel and share voting and dispositive power with respect to the shares held by the AH Parallel Fund III Entities. F6: (Continued from Footnote 5) Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Parallel Fund III Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.
Class B Common StockSEC Table II · derivative / convertible security	IndirectBy a16z Seed-III, LLC	0	Reported balance After 2021-05-21 transaction · row 20 Instrument identity requires review; Table II rows are not merged. 1 source row Row 20 · 2021-05-21 · Conversion · Disposed 322,110 · Balance 0 F2: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date. F7: Represents the conversion of 322,110 shares of Class B Common Stock held of record by a16z Seed-III, LLC ("a16z Seed") into Class A Common Stock. F8: These securities are held of record by a16z Seed. The securities held directly by a16z Seed are indirectly held by the AH Fund III Entities, the members of a16z Seed. AH EP III, the general partner of the AH Fund III Entities, has sole voting and dispositive power with regard to the shares held by a16z Seed. Marc Andreessen and Ben Horowitz are the managing members of AH EP III and share voting and dispositive power with respect to the shares held by a16z Seed. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by a16z Seed and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.

Filing footnotes · ownership attribution and instrument terms

F1: Represents the conversion of 5,220,839 shares of Class B Common Stock held of record by Andreessen Horowitz Fund III, L.P. into Class A Common Stock.

F2: Each share of Class B Common Stock is convertible into one share of Class A Common Stock at the option of the holder and has no expiration date.

F3: These securities are held by Andreessen Horowitz Fund III, L.P., for itself and as nominee for Andreessen Horowitz Fund III-A, L.P., Andreessen Horowitz Fund III-B, L.P., and Andreessen Horowitz Fund III-Q, L.P. (collectively, the "AH Fund III Entities"). AH Equity Partners III, L.L.C. ("AH EP III"), the general partner of the AH Fund III Entities, has sole voting and dispositive power with regard to the securities held by the AH Fund III Entities. Marc Andreessen and Ben Horowitz are the managing members of AH EP III and share voting and dispositive power with respect to the shares held by the AH Fund III Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Fund III Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.

F4: Represents the conversion of 454,334 shares of Class B Common Stock held of record by AH Parallel Fund III, L.P. into Class A Common Stock.

F5: These securities are held by AH Parallel Fund III, L.P., for itself and as nominee for AH Parallel Fund III-A, L.P., AH Parallel Fund III-B, L.P., and AH Parallel Fund III-Q, L.P. (collectively, the "AH Parallel Fund III Entities"). AH Equity Partners III (Parallel), L.L.C. ("AH EP III Parallel"), the general partner of the AH Parallel Fund III Entities, has sole voting and dispositive power with regard to the shares held by the AH Parallel Fund III Entities. Marc Andreessen and Ben Horowitz are the managing members of AH EP III Parallel and share voting and dispositive power with respect to the shares held by the AH Parallel Fund III Entities.

F6: (Continued from Footnote 5) Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Parallel Fund III Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.

F7: Represents the conversion of 322,110 shares of Class B Common Stock held of record by a16z Seed-III, LLC ("a16z Seed") into Class A Common Stock.

F8: These securities are held of record by a16z Seed. The securities held directly by a16z Seed are indirectly held by the AH Fund III Entities, the members of a16z Seed. AH EP III, the general partner of the AH Fund III Entities, has sole voting and dispositive power with regard to the shares held by a16z Seed. Marc Andreessen and Ben Horowitz are the managing members of AH EP III and share voting and dispositive power with respect to the shares held by a16z Seed. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by a16z Seed and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.

F9: On May 21, 2021, a16z Seed distributed, for no consideration, 425,185 shares of the Issuer's Class A Common Stock (the "a16z Seed Shares") to the AH Fund III Entities, representing each such member's pro rata interest in such a16z Seed Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended.

F10: On May 21, 2021, the AH Fund III Entities distributed, for no consideration, 5,542,949 shares of the Issuer's Class A Common Stock (the "AH Fund III Shares") to their limited partners and to AH EP III, the general partner of the AH Fund III Entities, representing each such partner's pro rata interest in such AH Fund III Shares. On the same date, AH EP III distributed, for no consideration, the AH Fund III Shares it received in the distribution by the AH Fund III Entities to its members, representing each such member's pro rata interest in such AH Fund III Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended.

F11: On May 21, 2021, the AH Parallel Fund III Entities distributed, for no consideration, 454,334 shares of the Issuer's Class A Common Stock (the "AH Parallel Fund III Shares") to their limited partners and to AH EP III Parallel, the general partner of the AH Parallel Fund III Entities, representing each such partner's pro rata interest in such AH Parallel Fund III Shares. On the same date, AH EP III Parallel distributed, for no consideration, the AH Parallel Fund III Shares it received in the distribution by the AH Parallel Fund III Entities to its members, representing each such member's pro rata interest in such AH Parallel Fund III Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended.

F12: On May 21, 2021, the AH LSV Fund I Entities (as defined below) distributed, for no consideration, 1,154,711 shares of the Issuer's Class A Common Stock (the "AH LSV Fund I Shares") to their limited partners and to AH EP LSV I (as defined below), the general partner of the AH LSV Fund I Entities, representing each such partner's pro rata interest in such AH LSV Fund I Shares. On the same date, AH EP LSV I distributed, for no consideration, the AH LSV Fund I Shares it received in the distribution by the AH LSV Fund I Entities to its members, representing each such member's pro rata interest in such AH LSV Fund I Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended.

F13: These securities are held by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the "AH LSV Fund I Entities"). AH Equity Partners LSV I, L.L.C. ("AH EP LSV I"), the general partner of the AH LSV Fund I Entities, has sole voting and dispositive power with regard to the shares held by the AH LSV Fund I Entities. Marc Andreessen and Ben Horowitz are the managing members of AH EP LSV I and share voting and dispositive power with respect to the shares held by the AH LSV Fund I Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.

F14: Represents shares received by AH Capital Management, L.L.C. pursuant to pro rata distributions by AH EP III, AH EP III Parallel and AH EP LSV I, for no consideration, of shares of the Issuer's Class A Common Stock to their respective members. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended.

F15: The securities are held of record by AH Capital Management, L.L.C. The members of AH Capital Management, L.L.C. are Marc Andreessen and Ben Horowitz, who share voting and dispositive power with respect to the shares held by AH Capital Management, L.L.C. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by AH Capital Management, L.L.C. and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.

F16: Represents shares received by the 1997 Horowitz Family Trust pursuant to pro rata distributions by the AH Fund III Entities, the AH Parallel Fund III Entities, the AH LSV Fund I Entities, AH EP III, AH EP III Parallel, and AH EP LSV I, for no consideration, of shares of the Issuer's Class A Common Stock to their respective partners or members, as applicable. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended.

F17: These securities are held of record by a family trust for which Ben Horowitz is a trustee. Each of the Reporting Persons disclaims the existence of a "group" and, other than Ben Horowitz, disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.

F18: Represents the weighted average sale price. The lowest price at which shares were sold was $224.33 and the highest price at which shares were sold was $225.32. The Reporting Persons undertake to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or the Issuer's stockholders, full information regarding the total number of shares sold at each separate price within the ranges set forth in footnotes (18) through (23) to this Form 4.

F19: Represents the weighted average sale price. The lowest price at which shares were sold was $225.34 and the highest price at which shares were sold was $226.335.

F20: Represents the weighted average sale price. The lowest price at which shares were sold was $226.34 and the highest price at which shares were sold was $227.30.

F21: Represents the weighted average sale price. The lowest price at which shares were sold was $227.35 and the highest price at which shares were sold was $228.05.

F22: Represents the weighted average sale price. The lowest price at which shares were sold was $228.49 and the highest price at which shares were sold was $229.46.

F23: Represents the weighted average sale price. The lowest price at which shares were sold was $229.67 and the highest price at which shares were sold was $229.79.

Navan, Inc.

Report date January 07, 2026 · Filed January 09, 2026

Jointly reported with Andreessen Horowitz LSV Fund I, L.P., Andreessen Horowitz LSV Fund I-B, L.P., AH Equity Partners LSV I, L.L.C., Andreessen Horowitz LSV Fund II, L.P., Andreessen Horowitz LSV Fund II-B, L.P., Andreessen Horowitz LSV Fund II-Q, L.P., AH Equity Partners LSV II, L.L.C., Andreessen Marc L

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	IndirectBy Andreessen Horowitz LSV Fund II, L.P.	8,346,792	Reported balance After 2026-01-07 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2026-01-07 · Purchase · Acquired 46,337 · Balance 8,346,792 F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.80 to $18.21 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. F2: These shares are held of record by Andreessen Horowitz LSV Fund II, L.P. ("AH LSV Fund II"), for itself and as nominee for Andreessen Horowitz LSV Fund II-B, L.P. and Andreessen Horowitz LSV Fund II-Q, L.P. (collectively, the "AH LSV Fund II Entities"). AH Equity Partners LSV II, L.L.C. ("AH EP LSV II "), the general partner of AH LSV Fund II, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund II Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV II and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund II Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund II Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.
Class A Common StockSEC Table I · non-derivative	IndirectBy Andreessen Horowitz LSV Fund I, L.P.	6,757,090	Reported balance Holding disclosure · report date 2026-01-07 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 6,757,090 F3: These shares are held of record by Andreessen Horowitz LSV Fund I, L.P. ("AH LSV Fund I"), for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the "AH LSV Fund I Entities"). AH Equity Partners LSV I, L.L.C. ("AH EP LSV I"), the general partner of AH LSV Fund I, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund I Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV I and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund I Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.
Class A Common StockSEC Table I · non-derivative	IndirectBy Andreessen Horowitz LSV Fund III, L.P.	607,161	Reported balance Holding disclosure · report date 2026-01-07 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 607,161 F4: These shares are held of record by Andreessen Horowitz LSV Fund III, L.P. ("AH LSV Fund III"), for itself and as nominee for Andreessen Horowitz LSV Fund III-B, L.P., AH 2022 Annual Fund, L.P., AH 2022 Annual Fund-B, L.P. and AH 2022 Annual Fund-QC, L.P. (collectively, the "AH LSV Fund III Entities"). AH Equity Partners LSV III, L.L.C. ("AH EP LSV III"), the general partner of AH LSV Fund III, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund III Entities. F5: (Continued from Footnote 4) Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV III and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund III Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund III Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.
Class A Common StockSEC Table I · non-derivative	IndirectBy Andreessen Horowitz Fund V, L.P.	2,081,772	Reported balance Holding disclosure · report date 2026-01-07 · row 4 Holding and transaction disclosures are not merged. 1 source row Row 4 · Balance 2,081,772 F6: These shares are held of record by Andreessen Horowitz Fund V, L.P. ("AH Fund V"), for itself and as nominee for Andreessen Horowitz Fund V-A, L.P., Andreessen Horowitz Fund V-B, L.P. and Andreessen Horowitz Fund V-Q, L.P. (collectively, the "AH Fund V Entities"). AH Equity Partners V, L.L.C. ("AH EP V"), the general partner of AH Fund V, may be deemed to have sole voting and dispositive power over the shares held by the AH Fund V Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP V and may be deemed to have shared voting and dispositive power over the shares held by the AH Fund V Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Fund V Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.
Class A Common StockSEC Table I · non-derivative	IndirectBy CLF Partners, LP	17,001	Reported balance Holding disclosure · report date 2026-01-07 · row 5 Holding and transaction disclosures are not merged. 1 source row Row 5 · Balance 17,001 F7: These shares are held of record by CLF Partners, LP ("CLF"). AH EP V, the general partner of CLF, may be deemed to have sole voting and dispositive power over the shares held by CLF. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP V and may be deemed to have shared voting and dispositive power over the shares held by CLF. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by CLF and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.
Class A Common StockSEC Table I · non-derivative	IndirectBy AH Parallel Fund V, L.P.	10,408,860	Reported balance Holding disclosure · report date 2026-01-07 · row 6 Holding and transaction disclosures are not merged. 1 source row Row 6 · Balance 10,408,860 F8: These shares are held of record by AH Parallel Fund V, L.P. ("AH Parallel V"), for itself and as nominee for AH Parallel Fund V-A, L.P., AH Parallel Fund V-B, L.P., and AH Parallel Fund V-Q, L.P. (collectively, the "AH Parallel Fund V Entities"). AH Equity Partners V (Parallel), L.L.C. ("AH EP V Parallel"), the general partner of AH Parallel V, may be deemed to have sole voting and dispositive power over the shares held by the AH Parallel Fund V Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP V Parallel and may be deemed to have shared voting and dispositive power over the shares held by the AH Parallel Fund V Entities. F9: (Continued from Footnote 8) Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Parallel Fund V Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.

Filing footnotes · ownership attribution and instrument terms

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.80 to $18.21 inclusive. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

F2: These shares are held of record by Andreessen Horowitz LSV Fund II, L.P. ("AH LSV Fund II"), for itself and as nominee for Andreessen Horowitz LSV Fund II-B, L.P. and Andreessen Horowitz LSV Fund II-Q, L.P. (collectively, the "AH LSV Fund II Entities"). AH Equity Partners LSV II, L.L.C. ("AH EP LSV II "), the general partner of AH LSV Fund II, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund II Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV II and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund II Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund II Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.

F3: These shares are held of record by Andreessen Horowitz LSV Fund I, L.P. ("AH LSV Fund I"), for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the "AH LSV Fund I Entities"). AH Equity Partners LSV I, L.L.C. ("AH EP LSV I"), the general partner of AH LSV Fund I, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund I Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV I and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund I Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.

F4: These shares are held of record by Andreessen Horowitz LSV Fund III, L.P. ("AH LSV Fund III"), for itself and as nominee for Andreessen Horowitz LSV Fund III-B, L.P., AH 2022 Annual Fund, L.P., AH 2022 Annual Fund-B, L.P. and AH 2022 Annual Fund-QC, L.P. (collectively, the "AH LSV Fund III Entities"). AH Equity Partners LSV III, L.L.C. ("AH EP LSV III"), the general partner of AH LSV Fund III, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund III Entities.

F5: (Continued from Footnote 4) Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV III and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund III Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund III Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.

F6: These shares are held of record by Andreessen Horowitz Fund V, L.P. ("AH Fund V"), for itself and as nominee for Andreessen Horowitz Fund V-A, L.P., Andreessen Horowitz Fund V-B, L.P. and Andreessen Horowitz Fund V-Q, L.P. (collectively, the "AH Fund V Entities"). AH Equity Partners V, L.L.C. ("AH EP V"), the general partner of AH Fund V, may be deemed to have sole voting and dispositive power over the shares held by the AH Fund V Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP V and may be deemed to have shared voting and dispositive power over the shares held by the AH Fund V Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Fund V Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.

F7: These shares are held of record by CLF Partners, LP ("CLF"). AH EP V, the general partner of CLF, may be deemed to have sole voting and dispositive power over the shares held by CLF. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP V and may be deemed to have shared voting and dispositive power over the shares held by CLF. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by CLF and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.

F8: These shares are held of record by AH Parallel Fund V, L.P. ("AH Parallel V"), for itself and as nominee for AH Parallel Fund V-A, L.P., AH Parallel Fund V-B, L.P., and AH Parallel Fund V-Q, L.P. (collectively, the "AH Parallel Fund V Entities"). AH Equity Partners V (Parallel), L.L.C. ("AH EP V Parallel"), the general partner of AH Parallel V, may be deemed to have sole voting and dispositive power over the shares held by the AH Parallel Fund V Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP V Parallel and may be deemed to have shared voting and dispositive power over the shares held by the AH Parallel Fund V Entities.

F9: (Continued from Footnote 8) Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Parallel Fund V Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.

Past disclosures · reporting ended (2)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

EQRx, Inc.

Report date November 09, 2023 · Filed November 09, 2023

Jointly reported with AH Equity Partners LSV I, L.L.C., Andreessen Horowitz LSV Fund I, L.P., Andreessen Horowitz LSV Fund I-B, L.P., AH Equity Partners LSV II, L.L.C., Andreessen Horowitz LSV Fund II, L.P., Andreessen Horowitz LSV Fund II-B, L.P., Andreessen Horowitz LSV Fund II-Q, L.P., Andreessen Marc L, HOROWITZ BENJAMIN A

Section 16 reporting ended · disclosed 2023-11-09. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	IndirectBy AD Holdings, LLC	Reported balance After 2023-11-09 transaction · row 1 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 1 · 2023-11-09 · Other · Disposed 12,264 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated July 31, 2023 (the "Merger Agreement"), by and among the Issuer, Revolution Medicines, Inc. ("Revolution Medicines"), Equinox Merger Sub, Inc., a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub I"), and Equinox Merger Sub II LLC, a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub II"), pursuant to which Merger Sub I merged with and into the Issuer effective as of November 9, 2023 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines (the "First Merger"), and promptly after the First Merger, the Issuer merged with and into Merger Sub II, with Merger Sub II surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines. F2: At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Revolution Medicines common stock equal to 0.1112 (the "Exchange Ratio") and cash in lieu of any fractional shares of Revolution Medicines common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. F3: The reported securities are held by AD Holdings, LLC, of which Marc Andreessen is a manager. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by AD Holdings, LLC (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any.
Common StockSEC Table I · non-derivative	IndirectBy AH Bio Fund II, L.P.	Reported balance After 2023-11-09 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 2 · 2023-11-09 · Other · Disposed 17,438,465 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated July 31, 2023 (the "Merger Agreement"), by and among the Issuer, Revolution Medicines, Inc. ("Revolution Medicines"), Equinox Merger Sub, Inc., a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub I"), and Equinox Merger Sub II LLC, a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub II"), pursuant to which Merger Sub I merged with and into the Issuer effective as of November 9, 2023 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines (the "First Merger"), and promptly after the First Merger, the Issuer merged with and into Merger Sub II, with Merger Sub II surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines. F2: At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Revolution Medicines common stock equal to 0.1112 (the "Exchange Ratio") and cash in lieu of any fractional shares of Revolution Medicines common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. F4: The reported securities are held by AH Bio Fund II, L.P., for itself and as nominee for AH Bio Fund II-B, L.P. (collectively, the "AH Bio Fund II Entities"). AH Equity Partners Bio II, L.L.C. ("AH EP Bio II") is the general partner of the AH Bio Fund II Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH Bio Fund II Entities. The managing members of AH EP Bio II are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH Bio Fund II Entities. F5: Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Bio Fund II Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any.
Common StockSEC Table I · non-derivative	IndirectBy AH Bio Fund III, L.P.	Reported balance After 2023-11-09 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 3 · 2023-11-09 · Other · Disposed 19,192,015 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated July 31, 2023 (the "Merger Agreement"), by and among the Issuer, Revolution Medicines, Inc. ("Revolution Medicines"), Equinox Merger Sub, Inc., a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub I"), and Equinox Merger Sub II LLC, a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub II"), pursuant to which Merger Sub I merged with and into the Issuer effective as of November 9, 2023 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines (the "First Merger"), and promptly after the First Merger, the Issuer merged with and into Merger Sub II, with Merger Sub II surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines. F2: At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Revolution Medicines common stock equal to 0.1112 (the "Exchange Ratio") and cash in lieu of any fractional shares of Revolution Medicines common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. F6: The reported securities are held by AH Bio Fund III, L.P., for itself and as nominee for AH Bio Fund III-B, L.P. and AH Bio Fund III-Q, L.P. (collectively, the "AH Bio Fund III Entities"). AH Equity Partners Bio III, L.L.C. ("AH EP Bio III") is the general partner of the AH Bio Fund III Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH Bio Fund III Entities. The managing members of AH EP Bio III are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH Bio Fund III Entities. F7: Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Bio Fund III Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any.
Common StockSEC Table I · non-derivative	IndirectBy Andreessen Horowitz LSV Fund I, L.P.	Reported balance After 2023-11-09 transaction · row 4 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 4 · 2023-11-09 · Other · Disposed 11,433,677 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated July 31, 2023 (the "Merger Agreement"), by and among the Issuer, Revolution Medicines, Inc. ("Revolution Medicines"), Equinox Merger Sub, Inc., a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub I"), and Equinox Merger Sub II LLC, a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub II"), pursuant to which Merger Sub I merged with and into the Issuer effective as of November 9, 2023 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines (the "First Merger"), and promptly after the First Merger, the Issuer merged with and into Merger Sub II, with Merger Sub II surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines. F2: At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Revolution Medicines common stock equal to 0.1112 (the "Exchange Ratio") and cash in lieu of any fractional shares of Revolution Medicines common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. F8: The reported securities are held by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the "AH LSV Fund I Entities"). AH Equity Partners LSV I, L.L.C. ("AH EP LSV I") is the general partner of the AH LSV Fund I Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH LSV Fund I Entities. The managing members of AH EP LSV I are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH LSV Fund I Entities. F9: Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any.
Common StockSEC Table I · non-derivative	IndirectBy Andreessen Horowitz LSV Fund II, L.P.	Reported balance After 2023-11-09 transaction · row 5 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 5 · 2023-11-09 · Other · Disposed 5,000,000 · Balance 0 F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated July 31, 2023 (the "Merger Agreement"), by and among the Issuer, Revolution Medicines, Inc. ("Revolution Medicines"), Equinox Merger Sub, Inc., a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub I"), and Equinox Merger Sub II LLC, a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub II"), pursuant to which Merger Sub I merged with and into the Issuer effective as of November 9, 2023 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines (the "First Merger"), and promptly after the First Merger, the Issuer merged with and into Merger Sub II, with Merger Sub II surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines. F2: At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Revolution Medicines common stock equal to 0.1112 (the "Exchange Ratio") and cash in lieu of any fractional shares of Revolution Medicines common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. F10: The reported securities are held by Andreessen Horowitz LSV Fund II, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund II-B, L.P. and Andreessen Horowitz LSV Fund II-Q, L.P. (collectively, the "AH LSV Fund II Entities"). AH Equity Partners LSV II, L.L.C. ("AH EP LSV II") is the general partner of the AH LSV Fund II Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH LSV Fund II Entities. The managing members of AH EP LSV II are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH LSV Fund II Entities. F11: Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund II Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any.
Earn-out SharesSEC Table II · derivative / convertible security · Expires 2024-12-17	IndirectBy AH Bio Fund II, L.P.	Reported balance After 2023-11-09 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2023-11-09 · Other · Disposed 2,401,418 · Balance 0 F12: Pursuant to the terms of the Agreement and Plan of Merger dated August 5, 2021 (the "DeSPAC Merger Agreement"), by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.), AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the "AH Funds") were allocated the right to acquire an aggregate of 6,618,825 shares of Issuer common stock (the "Earn-out Shares"), (i) 4,633,177 of which will be released from escrow if the value weighted average price ("VWAP") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 1,985,648 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50. F13: Any Earn-out Shares not eligible to be released from escrow on or prior to the Effective Time, together with any other right, title or interest in or to such Earn-out Shares, are waived by the AH Funds and terminated. F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated July 31, 2023 (the "Merger Agreement"), by and among the Issuer, Revolution Medicines, Inc. ("Revolution Medicines"), Equinox Merger Sub, Inc., a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub I"), and Equinox Merger Sub II LLC, a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub II"), pursuant to which Merger Sub I merged with and into the Issuer effective as of November 9, 2023 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines (the "First Merger"), and promptly after the First Merger, the Issuer merged with and into Merger Sub II, with Merger Sub II surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines. F2: At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Revolution Medicines common stock equal to 0.1112 (the "Exchange Ratio") and cash in lieu of any fractional shares of Revolution Medicines common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. F14: Each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time and held in escrow subject to the earn-out on the terms and subject to the conditions of the DeSPAC Merger Agreement was converted in the same manner as all other shares of Issuer common stock under the Merger Agreement. F4: The reported securities are held by AH Bio Fund II, L.P., for itself and as nominee for AH Bio Fund II-B, L.P. (collectively, the "AH Bio Fund II Entities"). AH Equity Partners Bio II, L.L.C. ("AH EP Bio II") is the general partner of the AH Bio Fund II Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH Bio Fund II Entities. The managing members of AH EP Bio II are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH Bio Fund II Entities. F5: Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Bio Fund II Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any.
Earn-out SharesSEC Table II · derivative / convertible security · Expires 2024-12-17	IndirectBy AH Bio Fund III, L.P.	Reported balance After 2023-11-09 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2023-11-09 · Other · Disposed 2,642,897 · Balance 0 F12: Pursuant to the terms of the Agreement and Plan of Merger dated August 5, 2021 (the "DeSPAC Merger Agreement"), by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.), AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the "AH Funds") were allocated the right to acquire an aggregate of 6,618,825 shares of Issuer common stock (the "Earn-out Shares"), (i) 4,633,177 of which will be released from escrow if the value weighted average price ("VWAP") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 1,985,648 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50. F13: Any Earn-out Shares not eligible to be released from escrow on or prior to the Effective Time, together with any other right, title or interest in or to such Earn-out Shares, are waived by the AH Funds and terminated. F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated July 31, 2023 (the "Merger Agreement"), by and among the Issuer, Revolution Medicines, Inc. ("Revolution Medicines"), Equinox Merger Sub, Inc., a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub I"), and Equinox Merger Sub II LLC, a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub II"), pursuant to which Merger Sub I merged with and into the Issuer effective as of November 9, 2023 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines (the "First Merger"), and promptly after the First Merger, the Issuer merged with and into Merger Sub II, with Merger Sub II surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines. F2: At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Revolution Medicines common stock equal to 0.1112 (the "Exchange Ratio") and cash in lieu of any fractional shares of Revolution Medicines common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. F14: Each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time and held in escrow subject to the earn-out on the terms and subject to the conditions of the DeSPAC Merger Agreement was converted in the same manner as all other shares of Issuer common stock under the Merger Agreement. F6: The reported securities are held by AH Bio Fund III, L.P., for itself and as nominee for AH Bio Fund III-B, L.P. and AH Bio Fund III-Q, L.P. (collectively, the "AH Bio Fund III Entities"). AH Equity Partners Bio III, L.L.C. ("AH EP Bio III") is the general partner of the AH Bio Fund III Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH Bio Fund III Entities. The managing members of AH EP Bio III are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH Bio Fund III Entities. F7: Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Bio Fund III Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any.
Earn-out SharesSEC Table II · derivative / convertible security · Expires 2024-12-17	IndirectBy Andreessen Horowitz LSV Fund I, L.P.	Reported balance After 2023-11-09 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2023-11-09 · Other · Disposed 1,574,510 · Balance 0 F12: Pursuant to the terms of the Agreement and Plan of Merger dated August 5, 2021 (the "DeSPAC Merger Agreement"), by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.), AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the "AH Funds") were allocated the right to acquire an aggregate of 6,618,825 shares of Issuer common stock (the "Earn-out Shares"), (i) 4,633,177 of which will be released from escrow if the value weighted average price ("VWAP") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 1,985,648 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50. F13: Any Earn-out Shares not eligible to be released from escrow on or prior to the Effective Time, together with any other right, title or interest in or to such Earn-out Shares, are waived by the AH Funds and terminated. F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated July 31, 2023 (the "Merger Agreement"), by and among the Issuer, Revolution Medicines, Inc. ("Revolution Medicines"), Equinox Merger Sub, Inc., a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub I"), and Equinox Merger Sub II LLC, a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub II"), pursuant to which Merger Sub I merged with and into the Issuer effective as of November 9, 2023 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines (the "First Merger"), and promptly after the First Merger, the Issuer merged with and into Merger Sub II, with Merger Sub II surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines. F2: At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Revolution Medicines common stock equal to 0.1112 (the "Exchange Ratio") and cash in lieu of any fractional shares of Revolution Medicines common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. F14: Each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time and held in escrow subject to the earn-out on the terms and subject to the conditions of the DeSPAC Merger Agreement was converted in the same manner as all other shares of Issuer common stock under the Merger Agreement. F8: The reported securities are held by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the "AH LSV Fund I Entities"). AH Equity Partners LSV I, L.L.C. ("AH EP LSV I") is the general partner of the AH LSV Fund I Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH LSV Fund I Entities. The managing members of AH EP LSV I are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH LSV Fund I Entities. F9: Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any.

Filing footnotes · ownership attribution and instrument terms

F1: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated July 31, 2023 (the "Merger Agreement"), by and among the Issuer, Revolution Medicines, Inc. ("Revolution Medicines"), Equinox Merger Sub, Inc., a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub I"), and Equinox Merger Sub II LLC, a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub II"), pursuant to which Merger Sub I merged with and into the Issuer effective as of November 9, 2023 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines (the "First Merger"), and promptly after the First Merger, the Issuer merged with and into Merger Sub II, with Merger Sub II surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines.

F2: At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Revolution Medicines common stock equal to 0.1112 (the "Exchange Ratio") and cash in lieu of any fractional shares of Revolution Medicines common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement.

F3: The reported securities are held by AD Holdings, LLC, of which Marc Andreessen is a manager. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by AD Holdings, LLC (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any.

F4: The reported securities are held by AH Bio Fund II, L.P., for itself and as nominee for AH Bio Fund II-B, L.P. (collectively, the "AH Bio Fund II Entities"). AH Equity Partners Bio II, L.L.C. ("AH EP Bio II") is the general partner of the AH Bio Fund II Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH Bio Fund II Entities. The managing members of AH EP Bio II are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH Bio Fund II Entities.

F5: Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Bio Fund II Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any.

F6: The reported securities are held by AH Bio Fund III, L.P., for itself and as nominee for AH Bio Fund III-B, L.P. and AH Bio Fund III-Q, L.P. (collectively, the "AH Bio Fund III Entities"). AH Equity Partners Bio III, L.L.C. ("AH EP Bio III") is the general partner of the AH Bio Fund III Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH Bio Fund III Entities. The managing members of AH EP Bio III are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH Bio Fund III Entities.

F7: Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Bio Fund III Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any.

F8: The reported securities are held by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the "AH LSV Fund I Entities"). AH Equity Partners LSV I, L.L.C. ("AH EP LSV I") is the general partner of the AH LSV Fund I Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH LSV Fund I Entities. The managing members of AH EP LSV I are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH LSV Fund I Entities.

F9: Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any.

F10: The reported securities are held by Andreessen Horowitz LSV Fund II, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund II-B, L.P. and Andreessen Horowitz LSV Fund II-Q, L.P. (collectively, the "AH LSV Fund II Entities"). AH Equity Partners LSV II, L.L.C. ("AH EP LSV II") is the general partner of the AH LSV Fund II Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH LSV Fund II Entities. The managing members of AH EP LSV II are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH LSV Fund II Entities.

F11: Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund II Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any.

F12: Pursuant to the terms of the Agreement and Plan of Merger dated August 5, 2021 (the "DeSPAC Merger Agreement"), by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.), AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the "AH Funds") were allocated the right to acquire an aggregate of 6,618,825 shares of Issuer common stock (the "Earn-out Shares"), (i) 4,633,177 of which will be released from escrow if the value weighted average price ("VWAP") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 1,985,648 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50.

F13: Any Earn-out Shares not eligible to be released from escrow on or prior to the Effective Time, together with any other right, title or interest in or to such Earn-out Shares, are waived by the AH Funds and terminated.

F14: Each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time and held in escrow subject to the earn-out on the terms and subject to the conditions of the DeSPAC Merger Agreement was converted in the same manner as all other shares of Issuer common stock under the Merger Agreement.

Samsara Inc.

Report date September 08, 2025 · Filed September 11, 2025

Jointly reported with Andreessen Horowitz LSV Fund I, L.P., Andreessen Horowitz LSV Fund I-B, L.P., AH Equity Partners LSV I, L.L.C., Andreessen Horowitz Fund IV, L.P., Andreessen Horowitz Fund IV-A, L.P., Andreessen Horowitz Fund IV-B, L.P., Andreessen Horowitz Fund IV-Q, L.P., AH Equity Partners IV, L.L.C., HOROWITZ BENJAMIN A

Section 16 reporting ended · disclosed 2025-09-11. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Class A Common StockSEC Table I · non-derivative	IndirectBy Andreessen Horowitz LSV Fund I, L.P.	0	Last balance in matching sequence After 2025-09-09 transaction · row 11 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 4 source rows Row 1 · 2025-09-08 · Other · Disposed 1,255,907 · Balance 503,000 F1: On September 8, 2025, the AH LSV Fund I Entities (as defined below) distributed, for no consideration, 1,255,907 shares of the Issuer's Class A Common Stock (the "AH LSV Fund I Shares") to their limited partners and to AH Equity Partners LSV I, L.L.C. ("AH EP LSV I"), the general partner of the AH LSV Fund I Entities, representing each such partner's pro rata interest in such AH LSV Fund I Shares. On the same date, AH EP LSV I distributed, for no consideration, the AH LSV Fund I Shares it received in the distribution to its members, representing each such member's pro rata interest in such AH LSV Fund I Shares. The aforementioned distributions are collectively referred to herein as the "AH LSV Fund I Distribution." F2: These shares are held of record by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the "AH LSV Fund I Entities"). AH EP LSV I, the general partner of the AH LSV Fund I Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund I Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV I and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund I Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Row 7 · 2025-09-09 · Sale · Disposed 183,868 · Balance 319,132 F14: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.38 to $38.3789 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: These shares are held of record by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the "AH LSV Fund I Entities"). AH EP LSV I, the general partner of the AH LSV Fund I Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund I Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV I and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund I Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Row 9 · 2025-09-09 · Sale · Disposed 268,420 · Balance 50,712 F15: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.38 to $39.3791 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: These shares are held of record by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the "AH LSV Fund I Entities"). AH EP LSV I, the general partner of the AH LSV Fund I Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund I Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV I and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund I Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Row 11 · 2025-09-09 · Sale · Disposed 50,712 · Balance 0 F16: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.38 to $40.10 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2: These shares are held of record by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the "AH LSV Fund I Entities"). AH EP LSV I, the general partner of the AH LSV Fund I Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund I Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV I and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund I Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.
Class A Common StockSEC Table I · non-derivative	IndirectBy Andreessen Horowitz Fund IV, L.P.	0	Reported balance After 2025-09-08 transaction · row 2 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 2 · 2025-09-08 · Other · Disposed 10,949,014 · Balance 0 F3: On September 8, 2025, the AH Fund IV Entities (as defined below) distributed, for no consideration, 10,949,014 shares of the Issuer's Class A Common Stock (the "AH Fund IV Shares") to their limited partners and to AH Equity Partners IV, L.L.C. ("AH EP IV"), the general partner of the AH Fund IV Entities, representing each such partner's pro rata interest in such AH Fund IV Shares. On the same date, AH EP IV distributed, for no consideration, the AH Fund IV Shares it received in the distribution to its members, representing each such member's pro rata interest in such AH Fund IV Shares. The aforementioned distributions are collectively referred to herein as the "AH Fund IV Distribution." F4: These shares are held of record by Andreessen Horowitz Fund IV, L.P., for itself and as nominee for Andreessen Horowitz Fund IV-A, L.P., Andreessen Horowitz Fund IV-B, L.P., and Andreessen Horowitz Fund IV-Q, L.P. (collectively, the "AH Fund IV Entities"). AH EP IV, the general partner of the AH Fund IV Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH Fund IV Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP IV and may be deemed to have shared voting and dispositive power over the shares held by the AH Fund IV Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Fund IV Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.
Class A Common StockSEC Table I · non-derivative	IndirectBy AH Parallel Fund IV, L.P.	0	Reported balance After 2025-09-08 transaction · row 3 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 3 · 2025-09-08 · Other · Disposed 994,899 · Balance 0 F5: On September 8, 2025, the AH Parallel Fund IV Entities (as defined below) distributed, for no consideration, 994,899 shares of the Issuer's Class A Common Stock (the "AH Parallel Fund IV Shares") to their limited partners and to AH Equity Partners IV (Parallel), L.L.C. ("AH EP IV Parallel"), the general partner of the AH Parallel Fund IV Entities, representing each such partner's pro rata interest in such AH Parallel Fund IV Shares. On the same date, AH EP IV Parallel distributed, for no consideration, the AH Parallel Fund IV Shares it received in the distribution to its members, representing each such member's pro rata interest in such AH Parallel Fund IV Shares. The aforementioned distributions are collectively referred to herein as the "AH Parallel Fund IV Distribution." F6: These shares are held of record by AH Parallel Fund IV, L.P., for itself and as nominee for AH Parallel Fund IV-A, L.P., AH Parallel Fund IV-B, L.P., and AH Parallel Fund IV-Q, L.P. (collectively, the "AH Parallel Fund IV Entities"). AH EP IV Parallel, the general partner of the AH Parallel Fund IV Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH Parallel Fund IV Entities. F7: (Continued from Footnote 6) Marc Andreessen and Benjamin Horowitz are the managing members of AH EP IV Parallel and may be deemed to have shared voting and dispositive power over the shares held by the AH Parallel Fund IV Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Parallel Fund IV Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.
Class A Common StockSEC Table I · non-derivative	IndirectBy AH Parallel Fund V, L.P.	0	Last balance in matching sequence After 2025-09-09 transaction · row 12 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 4 source rows Row 4 · 2025-09-08 · Other · Disposed 2,573,745 · Balance 257,000 F8: On September 8, 2025, the AH Parallel Fund V Entities (as defined below) distributed, for no consideration, 2,316,745 shares of the Issuer's Class A Common Stock (the "AH Parallel Fund V Shares") to their limited partners and to AH Equity Partners V (Parallel), L.L.C. ("AH EP V Parallel"), the general partner of the AH Parallel Fund V Entities, representing each such partner's pro rata interest in such AH Parallel Fund V Shares. On the same date, AH EP V Parallel distributed, for no consideration, the AH Parallel Fund V Shares it received in the distribution to its members, representing each such member's pro rata interest in such AH Parallel Fund V Shares. The aforementioned distributions are collectively referred to herein as the "AH Parallel Fund V Distribution." F9: These shares are held of record by AH Parallel Fund V, L.P., for itself and as nominee for AH Parallel Fund V-A, L.P., AH Parallel Fund V-B, L.P., and AH Parallel Fund V-Q, L.P. (collectively, the "AH Parallel Fund V Entities"). AH EP V Parallel, the general partner of the AH Parallel Fund V Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH Parallel Fund V Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP V Parallel and may be deemed to have shared voting and dispositive power over the shares held by the AH Parallel Fund V Entities. F10: (Continued from Footnote 9) Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Parallel Fund V Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Row 8 · 2025-09-09 · Sale · Disposed 93,944 · Balance 163,056 F14: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.38 to $38.3789 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F9: These shares are held of record by AH Parallel Fund V, L.P., for itself and as nominee for AH Parallel Fund V-A, L.P., AH Parallel Fund V-B, L.P., and AH Parallel Fund V-Q, L.P. (collectively, the "AH Parallel Fund V Entities"). AH EP V Parallel, the general partner of the AH Parallel Fund V Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH Parallel Fund V Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP V Parallel and may be deemed to have shared voting and dispositive power over the shares held by the AH Parallel Fund V Entities. F10: (Continued from Footnote 9) Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Parallel Fund V Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Row 10 · 2025-09-09 · Sale · Disposed 137,145 · Balance 25,911 F15: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.38 to $39.3791 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F9: These shares are held of record by AH Parallel Fund V, L.P., for itself and as nominee for AH Parallel Fund V-A, L.P., AH Parallel Fund V-B, L.P., and AH Parallel Fund V-Q, L.P. (collectively, the "AH Parallel Fund V Entities"). AH EP V Parallel, the general partner of the AH Parallel Fund V Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH Parallel Fund V Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP V Parallel and may be deemed to have shared voting and dispositive power over the shares held by the AH Parallel Fund V Entities. F10: (Continued from Footnote 9) Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Parallel Fund V Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Row 12 · 2025-09-09 · Sale · Disposed 25,911 · Balance 0 F16: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.38 to $40.10 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F9: These shares are held of record by AH Parallel Fund V, L.P., for itself and as nominee for AH Parallel Fund V-A, L.P., AH Parallel Fund V-B, L.P., and AH Parallel Fund V-Q, L.P. (collectively, the "AH Parallel Fund V Entities"). AH EP V Parallel, the general partner of the AH Parallel Fund V Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH Parallel Fund V Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP V Parallel and may be deemed to have shared voting and dispositive power over the shares held by the AH Parallel Fund V Entities. F10: (Continued from Footnote 9) Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Parallel Fund V Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.
Class A Common StockSEC Table I · non-derivative	IndirectBy a16z Capital Management, L.L.C.	0	Last balance in matching sequence After 2025-09-09 transaction · row 15 Source-order balances reconcile. Account continuity and personal attribution are not independently verified. 4 source rows Row 5 · 2025-09-08 · Other · Acquired 33,331 · Balance 33,331 F11: These shares were acquired pursuant to the AH LSV Fund I Distribution, the AH Fund IV Distribution, the AH Parallel Fund IV Distribution and the AH Parallel Fund V Distribution. The acquisition of such shares was made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended. F12: These shares are held of record by a16z Capital Management, L.L.C. ("a16z Capital"). The members of a16z Capital are Marc Andreessen and Benjamin Horowitz, who share voting and dispositive power with respect to the shares held by a16z Capital. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by a16z Capital and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Row 13 · 2025-09-09 · Sale · Disposed 11,860 · Balance 21,471 F17: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.40 to $38.39 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F12: These shares are held of record by a16z Capital Management, L.L.C. ("a16z Capital"). The members of a16z Capital are Marc Andreessen and Benjamin Horowitz, who share voting and dispositive power with respect to the shares held by a16z Capital. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by a16z Capital and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Row 14 · 2025-09-09 · Sale · Disposed 18,163 · Balance 3,308 F18: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.41 to $39.40 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F12: These shares are held of record by a16z Capital Management, L.L.C. ("a16z Capital"). The members of a16z Capital are Marc Andreessen and Benjamin Horowitz, who share voting and dispositive power with respect to the shares held by a16z Capital. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by a16z Capital and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Row 15 · 2025-09-09 · Sale · Disposed 3,308 · Balance 0 F19: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.42 to $40.10 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F12: These shares are held of record by a16z Capital Management, L.L.C. ("a16z Capital"). The members of a16z Capital are Marc Andreessen and Benjamin Horowitz, who share voting and dispositive power with respect to the shares held by a16z Capital. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by a16z Capital and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.
Class A Common StockSEC Table I · non-derivative	IndirectBy 1997 Horowitz Family Trust	4,351,006	Reported balance After 2025-09-08 transaction · row 6 Joint disclosure: continuity of the reported position is unresolved; see ownership footnotes. 1 source row Row 6 · 2025-09-08 · Other · Acquired 868,485 · Balance 4,351,006 F11: These shares were acquired pursuant to the AH LSV Fund I Distribution, the AH Fund IV Distribution, the AH Parallel Fund IV Distribution and the AH Parallel Fund V Distribution. The acquisition of such shares was made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended. F13: These shares are held of record by the 1997 Horowitz Family Trust, of which Benjamin Horowitz is a trustee. Each of the Reporting Persons disclaims the existence of a "group" and, other than Benjamin Horowitz, disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.
Class A Common StockSEC Table I · non-derivative	IndirectBy Horowitz 2020 Dynasty Trust	749	Reported balance Holding disclosure · report date 2025-09-08 · row 16 Holding and transaction disclosures are not merged. 1 source row Row 16 · Balance 749 F20: These shares are held of record by the Horowitz 2020 Dynasty Trust. Benjamin Horowitz may be deemed to have shared voting and dispositive power over the shares held by this trust. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.

Filing footnotes · ownership attribution and instrument terms

F1: On September 8, 2025, the AH LSV Fund I Entities (as defined below) distributed, for no consideration, 1,255,907 shares of the Issuer's Class A Common Stock (the "AH LSV Fund I Shares") to their limited partners and to AH Equity Partners LSV I, L.L.C. ("AH EP LSV I"), the general partner of the AH LSV Fund I Entities, representing each such partner's pro rata interest in such AH LSV Fund I Shares. On the same date, AH EP LSV I distributed, for no consideration, the AH LSV Fund I Shares it received in the distribution to its members, representing each such member's pro rata interest in such AH LSV Fund I Shares. The aforementioned distributions are collectively referred to herein as the "AH LSV Fund I Distribution."

F2: These shares are held of record by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the "AH LSV Fund I Entities"). AH EP LSV I, the general partner of the AH LSV Fund I Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund I Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV I and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund I Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.

F3: On September 8, 2025, the AH Fund IV Entities (as defined below) distributed, for no consideration, 10,949,014 shares of the Issuer's Class A Common Stock (the "AH Fund IV Shares") to their limited partners and to AH Equity Partners IV, L.L.C. ("AH EP IV"), the general partner of the AH Fund IV Entities, representing each such partner's pro rata interest in such AH Fund IV Shares. On the same date, AH EP IV distributed, for no consideration, the AH Fund IV Shares it received in the distribution to its members, representing each such member's pro rata interest in such AH Fund IV Shares. The aforementioned distributions are collectively referred to herein as the "AH Fund IV Distribution."

F4: These shares are held of record by Andreessen Horowitz Fund IV, L.P., for itself and as nominee for Andreessen Horowitz Fund IV-A, L.P., Andreessen Horowitz Fund IV-B, L.P., and Andreessen Horowitz Fund IV-Q, L.P. (collectively, the "AH Fund IV Entities"). AH EP IV, the general partner of the AH Fund IV Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH Fund IV Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP IV and may be deemed to have shared voting and dispositive power over the shares held by the AH Fund IV Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Fund IV Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.

F5: On September 8, 2025, the AH Parallel Fund IV Entities (as defined below) distributed, for no consideration, 994,899 shares of the Issuer's Class A Common Stock (the "AH Parallel Fund IV Shares") to their limited partners and to AH Equity Partners IV (Parallel), L.L.C. ("AH EP IV Parallel"), the general partner of the AH Parallel Fund IV Entities, representing each such partner's pro rata interest in such AH Parallel Fund IV Shares. On the same date, AH EP IV Parallel distributed, for no consideration, the AH Parallel Fund IV Shares it received in the distribution to its members, representing each such member's pro rata interest in such AH Parallel Fund IV Shares. The aforementioned distributions are collectively referred to herein as the "AH Parallel Fund IV Distribution."

F6: These shares are held of record by AH Parallel Fund IV, L.P., for itself and as nominee for AH Parallel Fund IV-A, L.P., AH Parallel Fund IV-B, L.P., and AH Parallel Fund IV-Q, L.P. (collectively, the "AH Parallel Fund IV Entities"). AH EP IV Parallel, the general partner of the AH Parallel Fund IV Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH Parallel Fund IV Entities.

F7: (Continued from Footnote 6) Marc Andreessen and Benjamin Horowitz are the managing members of AH EP IV Parallel and may be deemed to have shared voting and dispositive power over the shares held by the AH Parallel Fund IV Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Parallel Fund IV Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.

F8: On September 8, 2025, the AH Parallel Fund V Entities (as defined below) distributed, for no consideration, 2,316,745 shares of the Issuer's Class A Common Stock (the "AH Parallel Fund V Shares") to their limited partners and to AH Equity Partners V (Parallel), L.L.C. ("AH EP V Parallel"), the general partner of the AH Parallel Fund V Entities, representing each such partner's pro rata interest in such AH Parallel Fund V Shares. On the same date, AH EP V Parallel distributed, for no consideration, the AH Parallel Fund V Shares it received in the distribution to its members, representing each such member's pro rata interest in such AH Parallel Fund V Shares. The aforementioned distributions are collectively referred to herein as the "AH Parallel Fund V Distribution."

F9: These shares are held of record by AH Parallel Fund V, L.P., for itself and as nominee for AH Parallel Fund V-A, L.P., AH Parallel Fund V-B, L.P., and AH Parallel Fund V-Q, L.P. (collectively, the "AH Parallel Fund V Entities"). AH EP V Parallel, the general partner of the AH Parallel Fund V Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH Parallel Fund V Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP V Parallel and may be deemed to have shared voting and dispositive power over the shares held by the AH Parallel Fund V Entities.

F10: (Continued from Footnote 9) Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Parallel Fund V Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.

F11: These shares were acquired pursuant to the AH LSV Fund I Distribution, the AH Fund IV Distribution, the AH Parallel Fund IV Distribution and the AH Parallel Fund V Distribution. The acquisition of such shares was made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended.

F12: These shares are held of record by a16z Capital Management, L.L.C. ("a16z Capital"). The members of a16z Capital are Marc Andreessen and Benjamin Horowitz, who share voting and dispositive power with respect to the shares held by a16z Capital. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by a16z Capital and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.

F13: These shares are held of record by the 1997 Horowitz Family Trust, of which Benjamin Horowitz is a trustee. Each of the Reporting Persons disclaims the existence of a "group" and, other than Benjamin Horowitz, disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.

F14: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.38 to $38.3789 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F15: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.38 to $39.3791 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F16: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.38 to $40.10 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F17: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.40 to $38.39 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F18: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.41 to $39.40 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F19: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.42 to $40.10 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F20: These shares are held of record by the Horowitz 2020 Dynasty Trust. Benjamin Horowitz may be deemed to have shared voting and dispositive power over the shares held by this trust. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
November 09, 2023 Filed Nov 9, 2023 21:06 UTC	EQRx, Inc. EQRX · Entity 108311	OtherCommon Stock	5,000,000	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-23-020291 · doc4.xml · nonDerivative · entry 5 AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV II, L.L.C. · CIK 0001829384 · 10% owner Andreessen Horowitz LSV Fund II, L.P. · CIK 0001829357 · 10% owner Andreessen Horowitz LSV Fund II-B, L.P. · CIK 0001829459 · 10% owner Andreessen Horowitz LSV Fund II-Q, L.P. · CIK 0001829458 · 10% owner Andreessen Marc L · CIK 0001160077 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Andreessen Horowitz LSV Fund II, L.P. Disclosed balance after: 0 F1 · kind: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated July 31, 2023 (the "Merger Agreement"), by and among the Issuer, Revolution Medicines, Inc. ("Revolution Medicines"), Equinox Merger Sub, Inc., a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub I"), and Equinox Merger Sub II LLC, a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub II"), pursuant to which Merger Sub I merged with and into the Issuer effective as of November 9, 2023 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines (the "First Merger"), and promptly after the First Merger, the Issuer merged with and into Merger Sub II, with Merger Sub II surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines. F2 · price: At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Revolution Medicines common stock equal to 0.1112 (the "Exchange Ratio") and cash in lieu of any fractional shares of Revolution Medicines common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. F10 · ownership.nature: The reported securities are held by Andreessen Horowitz LSV Fund II, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund II-B, L.P. and Andreessen Horowitz LSV Fund II-Q, L.P. (collectively, the "AH LSV Fund II Entities"). AH Equity Partners LSV II, L.L.C. ("AH EP LSV II") is the general partner of the AH LSV Fund II Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH LSV Fund II Entities. The managing members of AH EP LSV II are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH LSV Fund II Entities. F11 · ownership.nature: Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund II Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any. Read SEC document
November 09, 2023 Filed Nov 9, 2023 21:06 UTC	EQRx, Inc. EQRX · Entity 108311	OtherCommon Stock	11,433,677	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-23-020291 · doc4.xml · nonDerivative · entry 4 AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV II, L.L.C. · CIK 0001829384 · 10% owner Andreessen Horowitz LSV Fund II, L.P. · CIK 0001829357 · 10% owner Andreessen Horowitz LSV Fund II-B, L.P. · CIK 0001829459 · 10% owner Andreessen Horowitz LSV Fund II-Q, L.P. · CIK 0001829458 · 10% owner Andreessen Marc L · CIK 0001160077 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Andreessen Horowitz LSV Fund I, L.P. Disclosed balance after: 0 F1 · kind: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated July 31, 2023 (the "Merger Agreement"), by and among the Issuer, Revolution Medicines, Inc. ("Revolution Medicines"), Equinox Merger Sub, Inc., a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub I"), and Equinox Merger Sub II LLC, a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub II"), pursuant to which Merger Sub I merged with and into the Issuer effective as of November 9, 2023 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines (the "First Merger"), and promptly after the First Merger, the Issuer merged with and into Merger Sub II, with Merger Sub II surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines. F2 · price: At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Revolution Medicines common stock equal to 0.1112 (the "Exchange Ratio") and cash in lieu of any fractional shares of Revolution Medicines common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. F8 · ownership.nature: The reported securities are held by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the "AH LSV Fund I Entities"). AH Equity Partners LSV I, L.L.C. ("AH EP LSV I") is the general partner of the AH LSV Fund I Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH LSV Fund I Entities. The managing members of AH EP LSV I are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH LSV Fund I Entities. F9 · ownership.nature: Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any. Read SEC document
November 09, 2023 Filed Nov 9, 2023 21:06 UTC	EQRx, Inc. EQRX · Entity 108311	OtherCommon Stock	19,192,015	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-23-020291 · doc4.xml · nonDerivative · entry 3 AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV II, L.L.C. · CIK 0001829384 · 10% owner Andreessen Horowitz LSV Fund II, L.P. · CIK 0001829357 · 10% owner Andreessen Horowitz LSV Fund II-B, L.P. · CIK 0001829459 · 10% owner Andreessen Horowitz LSV Fund II-Q, L.P. · CIK 0001829458 · 10% owner Andreessen Marc L · CIK 0001160077 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By AH Bio Fund III, L.P. Disclosed balance after: 0 F1 · kind: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated July 31, 2023 (the "Merger Agreement"), by and among the Issuer, Revolution Medicines, Inc. ("Revolution Medicines"), Equinox Merger Sub, Inc., a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub I"), and Equinox Merger Sub II LLC, a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub II"), pursuant to which Merger Sub I merged with and into the Issuer effective as of November 9, 2023 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines (the "First Merger"), and promptly after the First Merger, the Issuer merged with and into Merger Sub II, with Merger Sub II surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines. F2 · price: At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Revolution Medicines common stock equal to 0.1112 (the "Exchange Ratio") and cash in lieu of any fractional shares of Revolution Medicines common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. F6 · ownership.nature: The reported securities are held by AH Bio Fund III, L.P., for itself and as nominee for AH Bio Fund III-B, L.P. and AH Bio Fund III-Q, L.P. (collectively, the "AH Bio Fund III Entities"). AH Equity Partners Bio III, L.L.C. ("AH EP Bio III") is the general partner of the AH Bio Fund III Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH Bio Fund III Entities. The managing members of AH EP Bio III are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH Bio Fund III Entities. F7 · ownership.nature: Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Bio Fund III Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any. Read SEC document
November 09, 2023 Filed Nov 9, 2023 21:06 UTC	EQRx, Inc. EQRX · Entity 108311	OtherCommon Stock	17,438,465	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-23-020291 · doc4.xml · nonDerivative · entry 2 AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV II, L.L.C. · CIK 0001829384 · 10% owner Andreessen Horowitz LSV Fund II, L.P. · CIK 0001829357 · 10% owner Andreessen Horowitz LSV Fund II-B, L.P. · CIK 0001829459 · 10% owner Andreessen Horowitz LSV Fund II-Q, L.P. · CIK 0001829458 · 10% owner Andreessen Marc L · CIK 0001160077 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By AH Bio Fund II, L.P. Disclosed balance after: 0 F1 · kind: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated July 31, 2023 (the "Merger Agreement"), by and among the Issuer, Revolution Medicines, Inc. ("Revolution Medicines"), Equinox Merger Sub, Inc., a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub I"), and Equinox Merger Sub II LLC, a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub II"), pursuant to which Merger Sub I merged with and into the Issuer effective as of November 9, 2023 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines (the "First Merger"), and promptly after the First Merger, the Issuer merged with and into Merger Sub II, with Merger Sub II surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines. F2 · price: At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Revolution Medicines common stock equal to 0.1112 (the "Exchange Ratio") and cash in lieu of any fractional shares of Revolution Medicines common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. F4 · ownership.nature: The reported securities are held by AH Bio Fund II, L.P., for itself and as nominee for AH Bio Fund II-B, L.P. (collectively, the "AH Bio Fund II Entities"). AH Equity Partners Bio II, L.L.C. ("AH EP Bio II") is the general partner of the AH Bio Fund II Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH Bio Fund II Entities. The managing members of AH EP Bio II are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH Bio Fund II Entities. F5 · ownership.nature: Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Bio Fund II Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any. Read SEC document
November 09, 2023 Filed Nov 9, 2023 21:06 UTC	EQRx, Inc. EQRX · Entity 108311	OtherCommon Stock	12,264	Not disclosed	Not disclosed	Disclosure SEC source: 0000899243-23-020291 · doc4.xml · nonDerivative · entry 1 AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV II, L.L.C. · CIK 0001829384 · 10% owner Andreessen Horowitz LSV Fund II, L.P. · CIK 0001829357 · 10% owner Andreessen Horowitz LSV Fund II-B, L.P. · CIK 0001829459 · 10% owner Andreessen Horowitz LSV Fund II-Q, L.P. · CIK 0001829458 · 10% owner Andreessen Marc L · CIK 0001160077 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By AD Holdings, LLC Disclosed balance after: 0 F1 · kind: This Form 4 reports securities disposed of pursuant to the terms of the Agreement and Plan of Merger dated July 31, 2023 (the "Merger Agreement"), by and among the Issuer, Revolution Medicines, Inc. ("Revolution Medicines"), Equinox Merger Sub, Inc., a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub I"), and Equinox Merger Sub II LLC, a direct, wholly owned subsidiary of Revolution Medicines ("Merger Sub II"), pursuant to which Merger Sub I merged with and into the Issuer effective as of November 9, 2023 (the "Effective Time"), with the Issuer surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines (the "First Merger"), and promptly after the First Merger, the Issuer merged with and into Merger Sub II, with Merger Sub II surviving such merger as a direct, wholly owned subsidiary of Revolution Medicines. F2 · price: At the Effective Time, each share of Issuer common stock that was issued and outstanding immediately prior to the Effective Time was converted into the right to receive a number of validly issued, fully paid and non-assessable shares of Revolution Medicines common stock equal to 0.1112 (the "Exchange Ratio") and cash in lieu of any fractional shares of Revolution Medicines common stock any former holder of Issuer common stock would otherwise be entitled to receive, without interest and subject to any required tax withholding, upon the terms and subject to the conditions of the Merger Agreement. F3 · ownership.nature: The reported securities are held by AD Holdings, LLC, of which Marc Andreessen is a manager. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by AD Holdings, LLC (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any. Read SEC document
September 08, 2023 Filed Sep 13, 2023 01:48 UTC	Samsara Inc. IOT · Entity 3218	ConversionClass B Common Stock · Derivative	310,952	$0.00	$0.00	Disclosure SEC source: 0001104659-23-100174 · tm2326017-1_4seq1.xml · derivative · entry 10 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Andreessen Horowitz LSV Fund I, L.P. Disclosed balance after: 12,557,802 Underlying: Class A Common Stock · 310,952 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F9 · derivative.exercise_date: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F9 · derivative.expiration_date: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F5 · ownership.nature: These shares are held of record by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the "AH LSV Fund I Entities"). AH Equity Partners LSV I, L.L.C. ("AH EP LSV I"), the general partner of the AH LSV Fund I Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund I Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV I and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund I Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
September 08, 2023 Filed Sep 13, 2023 01:48 UTC	Samsara Inc. IOT · Entity 3218	ConversionClass B Common Stock · Derivative	80,978	$0.00	$0.00	Disclosure SEC source: 0001104659-23-100174 · tm2326017-1_4seq1.xml · derivative · entry 9 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By AH Parallel Fund V, L.P. Disclosed balance after: 5,516,864 Underlying: Class A Common Stock · 80,978 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F9 · derivative.exercise_date: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F9 · derivative.expiration_date: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F1 · ownership.nature: These shares are held of record by AH Parallel Fund V, L.P., for itself and as nominee for AH Parallel Fund V-A, L.P., AH Parallel Fund V-B, L.P., and AH Parallel Fund V-Q, L.P. (collectively, the "AH Parallel Fund V Entities"). AH Equity Partners V (Parallel), L.L.C. ("AH EP V Parallel"), the general partner of the AH Parallel Fund V Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH Parallel Fund V Entities. Marc Andreessen and Benjamin Horowitz are managing members of AH EP V Parallel and may be deemed to have shared voting and dispositive power over the shares held by the AH Parallel Fund V Entities. F2 · ownership.nature: (Continued from Footnote 1) Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Parallel Fund V Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
September 08, 2023 Filed Sep 13, 2023 01:48 UTC	Samsara Inc. IOT · Entity 3218	SaleClass A Common Stock	63,414	$31.48	$1,996,145.89	Disclosure SEC source: 0001104659-23-100174 · tm2326017-1_4seq1.xml · nonDerivative · entry 6 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Andreessen Horowitz LSV Fund I, L.P. Disclosed balance after: 0 F4 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on September 8, 2023. The actual sale prices ranged from a low of $31.24 to a high of $31.715, inclusive. Each of the Reporting Persons undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each price within the range. F5 · ownership.nature: These shares are held of record by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the "AH LSV Fund I Entities"). AH Equity Partners LSV I, L.L.C. ("AH EP LSV I"), the general partner of the AH LSV Fund I Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund I Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV I and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund I Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
September 08, 2023 Filed Sep 13, 2023 01:48 UTC	Samsara Inc. IOT · Entity 3218	SaleClass A Common Stock	247,538	$30.78	$7,619,467.18	Disclosure SEC source: 0001104659-23-100174 · tm2326017-1_4seq1.xml · nonDerivative · entry 5 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Andreessen Horowitz LSV Fund I, L.P. Disclosed balance after: 63,414 F3 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on September 8, 2023. The actual sale prices ranged from a low of $30.24 to a high of $31.235, inclusive. Each of the Reporting Persons undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each price within the range. F5 · ownership.nature: These shares are held of record by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the "AH LSV Fund I Entities"). AH Equity Partners LSV I, L.L.C. ("AH EP LSV I"), the general partner of the AH LSV Fund I Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund I Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV I and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund I Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
September 08, 2023 Filed Sep 13, 2023 01:48 UTC	Samsara Inc. IOT · Entity 3218	ConversionClass A Common Stock	310,952	$0.00	$0.00	Disclosure SEC source: 0001104659-23-100174 · tm2326017-1_4seq1.xml · nonDerivative · entry 4 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Andreessen Horowitz LSV Fund I, L.P. Disclosed balance after: 310,952 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · ownership.nature: These shares are held of record by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the "AH LSV Fund I Entities"). AH Equity Partners LSV I, L.L.C. ("AH EP LSV I"), the general partner of the AH LSV Fund I Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund I Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV I and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund I Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
September 08, 2023 Filed Sep 13, 2023 01:48 UTC	Samsara Inc. IOT · Entity 3218	SaleClass A Common Stock	16,514	$31.48	$519,827.69	Disclosure SEC source: 0001104659-23-100174 · tm2326017-1_4seq1.xml · nonDerivative · entry 3 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By AH Parallel Fund V, L.P. Disclosed balance after: 0 F4 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on September 8, 2023. The actual sale prices ranged from a low of $31.24 to a high of $31.715, inclusive. Each of the Reporting Persons undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each price within the range. F1 · ownership.nature: These shares are held of record by AH Parallel Fund V, L.P., for itself and as nominee for AH Parallel Fund V-A, L.P., AH Parallel Fund V-B, L.P., and AH Parallel Fund V-Q, L.P. (collectively, the "AH Parallel Fund V Entities"). AH Equity Partners V (Parallel), L.L.C. ("AH EP V Parallel"), the general partner of the AH Parallel Fund V Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH Parallel Fund V Entities. Marc Andreessen and Benjamin Horowitz are managing members of AH EP V Parallel and may be deemed to have shared voting and dispositive power over the shares held by the AH Parallel Fund V Entities. F2 · ownership.nature: (Continued from Footnote 1) Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Parallel Fund V Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
September 08, 2023 Filed Sep 13, 2023 01:48 UTC	Samsara Inc. IOT · Entity 3218	SaleClass A Common Stock	64,464	$30.78	$1,984,266.38	Disclosure SEC source: 0001104659-23-100174 · tm2326017-1_4seq1.xml · nonDerivative · entry 2 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By AH Parallel Fund V, L.P. Disclosed balance after: 16,514 F3 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on September 8, 2023. The actual sale prices ranged from a low of $30.24 to a high of $31.235, inclusive. Each of the Reporting Persons undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each price within the range. F1 · ownership.nature: These shares are held of record by AH Parallel Fund V, L.P., for itself and as nominee for AH Parallel Fund V-A, L.P., AH Parallel Fund V-B, L.P., and AH Parallel Fund V-Q, L.P. (collectively, the "AH Parallel Fund V Entities"). AH Equity Partners V (Parallel), L.L.C. ("AH EP V Parallel"), the general partner of the AH Parallel Fund V Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH Parallel Fund V Entities. Marc Andreessen and Benjamin Horowitz are managing members of AH EP V Parallel and may be deemed to have shared voting and dispositive power over the shares held by the AH Parallel Fund V Entities. F2 · ownership.nature: (Continued from Footnote 1) Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Parallel Fund V Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
September 08, 2023 Filed Sep 13, 2023 01:48 UTC	Samsara Inc. IOT · Entity 3218	ConversionClass A Common Stock	80,978	$0.00	$0.00	Disclosure SEC source: 0001104659-23-100174 · tm2326017-1_4seq1.xml · nonDerivative · entry 1 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By AH Parallel Fund V, L.P. Disclosed balance after: 80,978 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: These shares are held of record by AH Parallel Fund V, L.P., for itself and as nominee for AH Parallel Fund V-A, L.P., AH Parallel Fund V-B, L.P., and AH Parallel Fund V-Q, L.P. (collectively, the "AH Parallel Fund V Entities"). AH Equity Partners V (Parallel), L.L.C. ("AH EP V Parallel"), the general partner of the AH Parallel Fund V Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH Parallel Fund V Entities. Marc Andreessen and Benjamin Horowitz are managing members of AH EP V Parallel and may be deemed to have shared voting and dispositive power over the shares held by the AH Parallel Fund V Entities. F2 · ownership.nature: (Continued from Footnote 1) Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Parallel Fund V Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
June 08, 2023 Filed Jun 13, 2023 01:52 UTC	Samsara Inc. IOT · Entity 3218	ConversionClass B Common Stock · Derivative	331,545	$0.00	$0.00	Disclosure SEC source: 0001104659-23-070526 · tm2318428-2_4seq1.xml · derivative · entry 8 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Andreessen Horowitz LSV Fund I, L.P. Disclosed balance after: 12,868,754 Underlying: Class A Common Stock · 331,545 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F8 · derivative.exercise_date: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F8 · derivative.expiration_date: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F4 · ownership.nature: These shares are held of record by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the "AH LSV Fund I Entities"). AH Equity Partners LSV I, L.L.C. ("AH EP LSV I"), the general partner of the AH LSV Fund I Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund I Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV I and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund I Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
June 08, 2023 Filed Jun 13, 2023 01:52 UTC	Samsara Inc. IOT · Entity 3218	ConversionClass B Common Stock · Derivative	36,038	$0.00	$0.00	Disclosure SEC source: 0001104659-23-070526 · tm2318428-2_4seq1.xml · derivative · entry 7 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By AH Parallel Fund V, L.P. Disclosed balance after: 5,597,842 Underlying: Class A Common Stock · 36,038 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_price: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F8 · derivative.exercise_date: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F8 · derivative.expiration_date: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F1 · ownership.nature: These shares are held of record by AH Parallel Fund V, L.P., for itself and as nominee for AH Parallel Fund V-A, L.P., AH Parallel Fund V-B, L.P., and AH Parallel Fund V-Q, L.P. (collectively, the "AH Parallel Fund V Entities"). AH Equity Partners V (Parallel), L.L.C. ("AH EP V Parallel"), the general partner of the AH Parallel Fund V Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH Parallel Fund V Entities. Marc Andreessen and Benjamin Horowitz are managing members of AH EP V Parallel and may be deemed to have shared voting and dispositive power over the shares held by the AH Parallel Fund V Entities. F2 · ownership.nature: (Continued from Footnote 1) Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Parallel Fund V Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
June 08, 2023 Filed Jun 13, 2023 01:52 UTC	Samsara Inc. IOT · Entity 3218	SaleClass A Common Stock	331,545	$27.75	$9,199,975.90	Disclosure SEC source: 0001104659-23-070526 · tm2318428-2_4seq1.xml · nonDerivative · entry 4 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Andreessen Horowitz LSV Fund I, L.P. Disclosed balance after: 0 F3 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on June 8, 2023. The actual sale prices ranged from a low of $27.65 to a high of $27.87, inclusive. Each of the Reporting Persons undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each price within the range. F4 · ownership.nature: These shares are held of record by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the "AH LSV Fund I Entities"). AH Equity Partners LSV I, L.L.C. ("AH EP LSV I"), the general partner of the AH LSV Fund I Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund I Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV I and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund I Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
June 08, 2023 Filed Jun 13, 2023 01:52 UTC	Samsara Inc. IOT · Entity 3218	ConversionClass A Common Stock	331,545	$0.00	$0.00	Disclosure SEC source: 0001104659-23-070526 · tm2318428-2_4seq1.xml · nonDerivative · entry 3 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By Andreessen Horowitz LSV Fund I, L.P. Disclosed balance after: 331,545 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · ownership.nature: These shares are held of record by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the "AH LSV Fund I Entities"). AH Equity Partners LSV I, L.L.C. ("AH EP LSV I"), the general partner of the AH LSV Fund I Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund I Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV I and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund I Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
June 08, 2023 Filed Jun 13, 2023 01:52 UTC	Samsara Inc. IOT · Entity 3218	SaleClass A Common Stock	36,038	$27.75	$1,000,011.25	Disclosure SEC source: 0001104659-23-070526 · tm2318428-2_4seq1.xml · nonDerivative · entry 2 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By AH Parallel Fund V, L.P. Disclosed balance after: 0 F3 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on June 8, 2023. The actual sale prices ranged from a low of $27.65 to a high of $27.87, inclusive. Each of the Reporting Persons undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each price within the range. F1 · ownership.nature: These shares are held of record by AH Parallel Fund V, L.P., for itself and as nominee for AH Parallel Fund V-A, L.P., AH Parallel Fund V-B, L.P., and AH Parallel Fund V-Q, L.P. (collectively, the "AH Parallel Fund V Entities"). AH Equity Partners V (Parallel), L.L.C. ("AH EP V Parallel"), the general partner of the AH Parallel Fund V Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH Parallel Fund V Entities. Marc Andreessen and Benjamin Horowitz are managing members of AH EP V Parallel and may be deemed to have shared voting and dispositive power over the shares held by the AH Parallel Fund V Entities. F2 · ownership.nature: (Continued from Footnote 1) Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Parallel Fund V Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
June 08, 2023 Filed Jun 13, 2023 01:52 UTC	Samsara Inc. IOT · Entity 3218	ConversionClass A Common Stock	36,038	$0.00	$0.00	Disclosure SEC source: 0001104659-23-070526 · tm2318428-2_4seq1.xml · nonDerivative · entry 1 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · By AH Parallel Fund V, L.P. Disclosed balance after: 36,038 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: These shares are held of record by AH Parallel Fund V, L.P., for itself and as nominee for AH Parallel Fund V-A, L.P., AH Parallel Fund V-B, L.P., and AH Parallel Fund V-Q, L.P. (collectively, the "AH Parallel Fund V Entities"). AH Equity Partners V (Parallel), L.L.C. ("AH EP V Parallel"), the general partner of the AH Parallel Fund V Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH Parallel Fund V Entities. Marc Andreessen and Benjamin Horowitz are managing members of AH EP V Parallel and may be deemed to have shared voting and dispositive power over the shares held by the AH Parallel Fund V Entities. F2 · ownership.nature: (Continued from Footnote 1) Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Parallel Fund V Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
March 08, 2023 Filed Mar 11, 2023 02:49 UTC	Samsara Inc. IOT · Entity 3218	ConversionClass B Common Stock · Derivative	360,983	$0.00	$0.00	Disclosure SEC source: 0001104659-23-031376 · tm239110-2_4seq1.xml · derivative · entry 5 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Andreessen Horowitz LSV Fund I, L.P. Disclosed balance after: 13,200,299 Underlying: Class A Common Stock · 360,983 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F6 · derivative.exercise_date: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F6 · derivative.expiration_date: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F1 · ownership.nature: These shares are held of record by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the "AH LSV Fund I Entities"). AH Equity Partners LSV I, L.L.C. ("AH EP LSV I"), the general partner of the AH LSV Fund I Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund I Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV I and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund I Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
March 08, 2023 Filed Mar 11, 2023 02:49 UTC	Samsara Inc. IOT · Entity 3218	SaleClass A Common Stock	360,983	$20.92	$7,549,995.54	Disclosure SEC source: 0001104659-23-031376 · tm239110-2_4seq1.xml · nonDerivative · entry 2 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Andreessen Horowitz LSV Fund I, L.P. Disclosed balance after: 0 F2 · price: Represents the weighted-average sale price per share of a series of transactions, all of which were executed on March 8, 2023. The actual sale prices ranged from a low of $20.68 to a high of $21.215, inclusive. Each of the Reporting Persons undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each price within the range. F1 · ownership.nature: These shares are held of record by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the "AH LSV Fund I Entities"). AH Equity Partners LSV I, L.L.C. ("AH EP LSV I"), the general partner of the AH LSV Fund I Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund I Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV I and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund I Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
March 08, 2023 Filed Mar 11, 2023 02:49 UTC	Samsara Inc. IOT · Entity 3218	ConversionClass A Common Stock	360,983	$0.00	$0.00	Disclosure SEC source: 0001104659-23-031376 · tm239110-2_4seq1.xml · nonDerivative · entry 1 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Andreessen Horowitz LSV Fund I, L.P. Disclosed balance after: 360,983 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: These shares are held of record by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the "AH LSV Fund I Entities"). AH Equity Partners LSV I, L.L.C. ("AH EP LSV I"), the general partner of the AH LSV Fund I Entities, may be deemed to have sole voting and dispositive power over the shares held by the AH LSV Fund I Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV I and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund I Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities and this report shall not be deemed an admission that such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
January 01, 2023 Filed Jan 5, 2023 21:01 UTC	EQRx, Inc. EQRX · Entity 108311	GrantEarn-out Shares · Derivative	8,246	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-23-001393 · tm231679-13_4seq1.xml · derivative · entry 8 AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV II, L.L.C. · CIK 0001829384 · 10% owner Andreessen Horowitz LSV Fund II, L.P. · CIK 0001829357 · 10% owner Andreessen Horowitz LSV Fund II-B, L.P. · CIK 0001829459 · 10% owner Andreessen Horowitz LSV Fund II-Q, L.P. · CIK 0001829458 · 10% owner Andreessen Marc L · CIK 0001160077 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Andreessen Horowitz LSV Fund I, L.P. Disclosed balance after: 1,574,510 Underlying: Common Stock · 8,246 shares Expires 2024-12-17 F2 · derivative.exercise_price: On January 1, 2023, AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the "AH Funds") were allocated the right to acquire an aggregate of 34,665 additional shares of the Issuer's Common Stock (the "Earn-out Shares"), (i) 24,265 of which will be released from escrow if the value weighted average price ("VWAP") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 10,400 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50. F3 · derivative.exercise_price: (Continued from Footnote 2) Any Earn-out Shares not eligible to be released on or prior to December 17, 2024 will be forfeited and cancelled, and the maximum number of Earn-out Shares the AH Funds may be eligible to acquire is subject to adjustment per the terms of the Agreement and Plan of Merger dated August 5, 2021 by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.). F2 · kind: On January 1, 2023, AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the "AH Funds") were allocated the right to acquire an aggregate of 34,665 additional shares of the Issuer's Common Stock (the "Earn-out Shares"), (i) 24,265 of which will be released from escrow if the value weighted average price ("VWAP") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 10,400 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50. F3 · kind: (Continued from Footnote 2) Any Earn-out Shares not eligible to be released on or prior to December 17, 2024 will be forfeited and cancelled, and the maximum number of Earn-out Shares the AH Funds may be eligible to acquire is subject to adjustment per the terms of the Agreement and Plan of Merger dated August 5, 2021 by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.). F2 · price: On January 1, 2023, AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the "AH Funds") were allocated the right to acquire an aggregate of 34,665 additional shares of the Issuer's Common Stock (the "Earn-out Shares"), (i) 24,265 of which will be released from escrow if the value weighted average price ("VWAP") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 10,400 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50. F3 · price: (Continued from Footnote 2) Any Earn-out Shares not eligible to be released on or prior to December 17, 2024 will be forfeited and cancelled, and the maximum number of Earn-out Shares the AH Funds may be eligible to acquire is subject to adjustment per the terms of the Agreement and Plan of Merger dated August 5, 2021 by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.). F2 · derivative.exercise_date: On January 1, 2023, AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the "AH Funds") were allocated the right to acquire an aggregate of 34,665 additional shares of the Issuer's Common Stock (the "Earn-out Shares"), (i) 24,265 of which will be released from escrow if the value weighted average price ("VWAP") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 10,400 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50. F3 · derivative.exercise_date: (Continued from Footnote 2) Any Earn-out Shares not eligible to be released on or prior to December 17, 2024 will be forfeited and cancelled, and the maximum number of Earn-out Shares the AH Funds may be eligible to acquire is subject to adjustment per the terms of the Agreement and Plan of Merger dated August 5, 2021 by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.). F8 · ownership.nature: The reported securities are held by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the "AH LSV Fund I Entities"). AH Equity Partners LSV I, L.L.C. ("AH EP LSV I") is the general partner of the AH LSV Fund I Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH LSV Fund I Entities. The managing members of AH EP LSV I are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH LSV Fund I Entities. F9 · ownership.nature: Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any. Read SEC document
January 01, 2023 Filed Jan 5, 2023 21:01 UTC	EQRx, Inc. EQRX · Entity 108311	GrantEarn-out Shares · Derivative	13,842	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-23-001393 · tm231679-13_4seq1.xml · derivative · entry 7 AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV II, L.L.C. · CIK 0001829384 · 10% owner Andreessen Horowitz LSV Fund II, L.P. · CIK 0001829357 · 10% owner Andreessen Horowitz LSV Fund II-B, L.P. · CIK 0001829459 · 10% owner Andreessen Horowitz LSV Fund II-Q, L.P. · CIK 0001829458 · 10% owner Andreessen Marc L · CIK 0001160077 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By AH Bio Fund III, L.P. Disclosed balance after: 2,642,897 Underlying: Common Stock · 13,842 shares Expires 2024-12-17 F2 · derivative.exercise_price: On January 1, 2023, AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the "AH Funds") were allocated the right to acquire an aggregate of 34,665 additional shares of the Issuer's Common Stock (the "Earn-out Shares"), (i) 24,265 of which will be released from escrow if the value weighted average price ("VWAP") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 10,400 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50. F3 · derivative.exercise_price: (Continued from Footnote 2) Any Earn-out Shares not eligible to be released on or prior to December 17, 2024 will be forfeited and cancelled, and the maximum number of Earn-out Shares the AH Funds may be eligible to acquire is subject to adjustment per the terms of the Agreement and Plan of Merger dated August 5, 2021 by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.). F2 · kind: On January 1, 2023, AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the "AH Funds") were allocated the right to acquire an aggregate of 34,665 additional shares of the Issuer's Common Stock (the "Earn-out Shares"), (i) 24,265 of which will be released from escrow if the value weighted average price ("VWAP") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 10,400 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50. F3 · kind: (Continued from Footnote 2) Any Earn-out Shares not eligible to be released on or prior to December 17, 2024 will be forfeited and cancelled, and the maximum number of Earn-out Shares the AH Funds may be eligible to acquire is subject to adjustment per the terms of the Agreement and Plan of Merger dated August 5, 2021 by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.). F2 · price: On January 1, 2023, AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the "AH Funds") were allocated the right to acquire an aggregate of 34,665 additional shares of the Issuer's Common Stock (the "Earn-out Shares"), (i) 24,265 of which will be released from escrow if the value weighted average price ("VWAP") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 10,400 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50. F3 · price: (Continued from Footnote 2) Any Earn-out Shares not eligible to be released on or prior to December 17, 2024 will be forfeited and cancelled, and the maximum number of Earn-out Shares the AH Funds may be eligible to acquire is subject to adjustment per the terms of the Agreement and Plan of Merger dated August 5, 2021 by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.). F2 · derivative.exercise_date: On January 1, 2023, AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the "AH Funds") were allocated the right to acquire an aggregate of 34,665 additional shares of the Issuer's Common Stock (the "Earn-out Shares"), (i) 24,265 of which will be released from escrow if the value weighted average price ("VWAP") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 10,400 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50. F3 · derivative.exercise_date: (Continued from Footnote 2) Any Earn-out Shares not eligible to be released on or prior to December 17, 2024 will be forfeited and cancelled, and the maximum number of Earn-out Shares the AH Funds may be eligible to acquire is subject to adjustment per the terms of the Agreement and Plan of Merger dated August 5, 2021 by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.). F6 · ownership.nature: The reported securities are held by AH Bio Fund III, L.P., for itself and as nominee for AH Bio Fund III-B, L.P. and AH Bio Fund III-Q, L.P. (collectively, the "AH Bio Fund III Entities"). AH Equity Partners Bio III, L.L.C. ("AH EP Bio III") is the general partner of the AH Bio Fund III Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH Bio Fund III Entities. The managing members of AH EP Bio III are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH Bio Fund III Entities. F7 · ownership.nature: Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Bio Fund III Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any. Read SEC document
January 01, 2023 Filed Jan 5, 2023 21:01 UTC	EQRx, Inc. EQRX · Entity 108311	GrantEarn-out Shares · Derivative	12,577	Not disclosed	Not disclosed	Disclosure SEC source: 0001104659-23-001393 · tm231679-13_4seq1.xml · derivative · entry 6 AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV II, L.L.C. · CIK 0001829384 · 10% owner Andreessen Horowitz LSV Fund II, L.P. · CIK 0001829357 · 10% owner Andreessen Horowitz LSV Fund II-B, L.P. · CIK 0001829459 · 10% owner Andreessen Horowitz LSV Fund II-Q, L.P. · CIK 0001829458 · 10% owner Andreessen Marc L · CIK 0001160077 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By AH Bio Fund II, L.P. Disclosed balance after: 2,401,418 Underlying: Common Stock · 12,577 shares Expires 2024-12-17 F2 · derivative.exercise_price: On January 1, 2023, AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the "AH Funds") were allocated the right to acquire an aggregate of 34,665 additional shares of the Issuer's Common Stock (the "Earn-out Shares"), (i) 24,265 of which will be released from escrow if the value weighted average price ("VWAP") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 10,400 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50. F3 · derivative.exercise_price: (Continued from Footnote 2) Any Earn-out Shares not eligible to be released on or prior to December 17, 2024 will be forfeited and cancelled, and the maximum number of Earn-out Shares the AH Funds may be eligible to acquire is subject to adjustment per the terms of the Agreement and Plan of Merger dated August 5, 2021 by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.). F2 · kind: On January 1, 2023, AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the "AH Funds") were allocated the right to acquire an aggregate of 34,665 additional shares of the Issuer's Common Stock (the "Earn-out Shares"), (i) 24,265 of which will be released from escrow if the value weighted average price ("VWAP") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 10,400 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50. F3 · kind: (Continued from Footnote 2) Any Earn-out Shares not eligible to be released on or prior to December 17, 2024 will be forfeited and cancelled, and the maximum number of Earn-out Shares the AH Funds may be eligible to acquire is subject to adjustment per the terms of the Agreement and Plan of Merger dated August 5, 2021 by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.). F2 · price: On January 1, 2023, AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the "AH Funds") were allocated the right to acquire an aggregate of 34,665 additional shares of the Issuer's Common Stock (the "Earn-out Shares"), (i) 24,265 of which will be released from escrow if the value weighted average price ("VWAP") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 10,400 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50. F3 · price: (Continued from Footnote 2) Any Earn-out Shares not eligible to be released on or prior to December 17, 2024 will be forfeited and cancelled, and the maximum number of Earn-out Shares the AH Funds may be eligible to acquire is subject to adjustment per the terms of the Agreement and Plan of Merger dated August 5, 2021 by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.). F2 · derivative.exercise_date: On January 1, 2023, AH Bio Fund II, L.P., AH Bio Fund III, L.P. and Andreessen Horowitz LSV Fund I, L.P. (together, the "AH Funds") were allocated the right to acquire an aggregate of 34,665 additional shares of the Issuer's Common Stock (the "Earn-out Shares"), (i) 24,265 of which will be released from escrow if the value weighted average price ("VWAP") for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $12.50; and (ii) 10,400 of which will be released from such escrow if the VWAP for at least 20 of any 30 consecutive trading days following December 17, 2022 is at least $16.50. F3 · derivative.exercise_date: (Continued from Footnote 2) Any Earn-out Shares not eligible to be released on or prior to December 17, 2024 will be forfeited and cancelled, and the maximum number of Earn-out Shares the AH Funds may be eligible to acquire is subject to adjustment per the terms of the Agreement and Plan of Merger dated August 5, 2021 by and among the Issuer (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx, Inc.). F4 · ownership.nature: The reported securities are held by AH Bio Fund II, L.P., for itself and as nominee for AH Bio Fund II-B, L.P. (collectively, the "AH Bio Fund II Entities"). AH Equity Partners Bio II, L.L.C. ("AH EP Bio II") is the general partner of the AH Bio Fund II Entities and may be deemed to have sole voting and dispositive power with regard to the securities held by the AH Bio Fund II Entities. The managing members of AH EP Bio II are Marc Andreessen and Ben Horowitz. Marc Andreessen and Ben Horowitz may be deemed to have shared voting and dispositive power with respect to the securities held by the AH Bio Fund II Entities. F5 · ownership.nature: Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Bio Fund II Entities (and this report shall not be deemed an admission that any such person is the beneficial owner of such securities), except to the extent of such person's pecuniary interest therein, if any. Read SEC document
September 07, 2022 Filed Sep 9, 2022 01:01 UTC	Samsara Inc. IOT · Entity 3218	SaleClass A Common Stock	242	$12.54	$3,034.95	Disclosure SEC source: 0001209191-22-049248 · doc4.xml · nonDerivative · entry 5 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By AH Capital Management, L.L.C. Disclosed balance after: 0 F6 · price: This transaction was executed in multiple trades at prices ranging from $12.19 to $12.82. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. F5 · ownership.nature: These shares are held of record by AH Capital Management, L.L.C. ("AH Capital"). The members of AH Capital are Marc Andreessen and Benjamin Horowitz, who share voting and dispositive power with respect to the shares held by AH Capital. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by AH Capital and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
September 06, 2022 Filed Sep 9, 2022 01:01 UTC	Samsara Inc. IOT · Entity 3218	ConversionClass B Common Stock · Derivative	3,271,524	$0.00	$0.00	Disclosure SEC source: 0001209191-22-049248 · doc4.xml · derivative · entry 7 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Andreessen Horowitz Fund IV, L.P. Disclosed balance after: 54,745,078 Underlying: Class A Common Stock · 3,271,524 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_price: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F9 · derivative.exercise_date: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F9 · derivative.expiration_date: The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F1 · ownership.nature: These shares are held of record by Andreessen Horowitz Fund IV, L.P., for itself and as nominee for Andreessen Horowitz Fund IV-A, L.P., Andreessen Horowitz Fund IV-B, L.P., and Andreessen Horowitz Fund IV-Q, L.P. (collectively, the "AH Fund IV Entities"). AH Equity Partners IV, L.L.C. ("AH EP IV"), the general partner of the AH Fund IV Entities, may be deemed to have sole voting and dispositive power over the securities held by the AH Fund IV Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP IV and may be deemed to have shared voting and dispositive power over the shares held by the AH Fund IV Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Fund IV Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
September 06, 2022 Filed Sep 9, 2022 01:01 UTC	Samsara Inc. IOT · Entity 3218	OtherClass A Common Stock	242	$0.00	$0.00	Disclosure SEC source: 0001209191-22-049248 · doc4.xml · nonDerivative · entry 4 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By AH Capital Management, L.L.C. Disclosed balance after: 242 F3 · kind: These shares were acquired pursuant to the Distribution. The acquisition of such shares was made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended. F5 · ownership.nature: These shares are held of record by AH Capital Management, L.L.C. ("AH Capital"). The members of AH Capital are Marc Andreessen and Benjamin Horowitz, who share voting and dispositive power with respect to the shares held by AH Capital. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by AH Capital and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
September 06, 2022 Filed Sep 9, 2022 01:01 UTC	Samsara Inc. IOT · Entity 3218	OtherClass A Common Stock	29,797	$0.00	$0.00	Disclosure SEC source: 0001209191-22-049248 · doc4.xml · nonDerivative · entry 3 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By 1997 Horowitz Family Trust Disclosed balance after: 29,797 F3 · kind: These shares were acquired pursuant to the Distribution. The acquisition of such shares was made in accordance with the exemptions afforded by Rules 16a-13 and/or 16a-9 of the Securities Exchange Act of 1934, as amended. F4 · ownership.nature: These shares are held of record by the 1997 Horowitz Family Trust, of which Benjamin Horowitz is a trustee. Each of the Reporting Persons disclaims the existence of a "group" and, other than Benjamin Horowitz, disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
September 06, 2022 Filed Sep 9, 2022 01:01 UTC	Samsara Inc. IOT · Entity 3218	OtherClass A Common Stock	3,271,524	$0.00	$0.00	Disclosure SEC source: 0001209191-22-049248 · doc4.xml · nonDerivative · entry 2 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Andreessen Horowitz Fund IV, L.P. Disclosed balance after: 0 F2 · kind: On September 6, 2022, the AH Fund IV Entities distributed, for no consideration, 3,271,524 shares of the Issuer's Class A Common Stock (the "AH Fund IV Shares") to their limited partners and to AH EP IV, the general partner of the AH Fund IV Entities, representing each such partner's pro rata interest in such AH Fund IV Shares. On the same date, AH EP IV distributed, for no consideration, the AH Fund IV Shares it received in the distribution to its members, representing each such member's pro rata interest in such AH Fund IV Shares. The aforementioned distributions are collectively referred to herein as the "Distribution." F1 · ownership.nature: These shares are held of record by Andreessen Horowitz Fund IV, L.P., for itself and as nominee for Andreessen Horowitz Fund IV-A, L.P., Andreessen Horowitz Fund IV-B, L.P., and Andreessen Horowitz Fund IV-Q, L.P. (collectively, the "AH Fund IV Entities"). AH Equity Partners IV, L.L.C. ("AH EP IV"), the general partner of the AH Fund IV Entities, may be deemed to have sole voting and dispositive power over the securities held by the AH Fund IV Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP IV and may be deemed to have shared voting and dispositive power over the shares held by the AH Fund IV Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Fund IV Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
September 06, 2022 Filed Sep 9, 2022 01:01 UTC	Samsara Inc. IOT · Entity 3218	ConversionClass A Common Stock	3,271,524	$0.00	$0.00	Disclosure SEC source: 0001209191-22-049248 · doc4.xml · nonDerivative · entry 1 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Andreessen Horowitz Fund IV, L.P. Disclosed balance after: 3,271,524 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: These shares are held of record by Andreessen Horowitz Fund IV, L.P., for itself and as nominee for Andreessen Horowitz Fund IV-A, L.P., Andreessen Horowitz Fund IV-B, L.P., and Andreessen Horowitz Fund IV-Q, L.P. (collectively, the "AH Fund IV Entities"). AH Equity Partners IV, L.L.C. ("AH EP IV"), the general partner of the AH Fund IV Entities, may be deemed to have sole voting and dispositive power over the securities held by the AH Fund IV Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP IV and may be deemed to have shared voting and dispositive power over the shares held by the AH Fund IV Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Fund IV Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
December 17, 2021 Filed Dec 22, 2021 02:50 UTC	Samsara Inc. IOT · Entity 3218	ConversionClass B Common Stock · Derivative	13,561,282	$0.00	$0.00	Disclosure SEC source: 0000899243-21-049321 · doc4.xml · derivative · entry 15 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Andreessen Horowitz LSV Fund I, L.P. Disclosed balance after: 13,561,282 Underlying: Class A Common Stock · 13,561,282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F9 · ownership.nature: These securities are held of record by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the "AH LSV Fund I Entities"). AH Equity Partners LSV I, L.L.C. ("AH EP LSV I"), the general partner of the AH LSV Fund I Entities, may be deemed to have sole voting and dispositive power over the securities held by the AH LSV Fund I Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV I and may be deemed to have shared voting and dispositive power over the securities held by the AH LSV Fund I Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
December 17, 2021 Filed Dec 22, 2021 02:50 UTC	Samsara Inc. IOT · Entity 3218	ConversionSeries F Preferred Stock · Derivative	13,561,282	$0.00	$0.00	Disclosure SEC source: 0000899243-21-049321 · doc4.xml · derivative · entry 14 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Andreessen Horowitz LSV Fund I, L.P. Disclosed balance after: 0 Underlying: Class B Common Stock · 13,561,282 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F9 · ownership.nature: These securities are held of record by Andreessen Horowitz LSV Fund I, L.P., for itself and as nominee for Andreessen Horowitz LSV Fund I-B, L.P. and Andreessen Horowitz LSV Fund I-Q, L.P. (collectively, the "AH LSV Fund I Entities"). AH Equity Partners LSV I, L.L.C. ("AH EP LSV I"), the general partner of the AH LSV Fund I Entities, may be deemed to have sole voting and dispositive power over the securities held by the AH LSV Fund I Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV I and may be deemed to have shared voting and dispositive power over the securities held by the AH LSV Fund I Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund I Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
December 17, 2021 Filed Dec 22, 2021 02:50 UTC	Samsara Inc. IOT · Entity 3218	ConversionClass B Common Stock · Derivative	5,633,880	$0.00	$0.00	Disclosure SEC source: 0000899243-21-049321 · doc4.xml · derivative · entry 13 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By AH Parallel Fund V, L.P. Disclosed balance after: 5,633,880 Underlying: Class A Common Stock · 5,633,880 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F7 · ownership.nature: These securities are held of record by AH Parallel Fund V, L.P., for itself and as nominee for AH Parallel Fund V-A, L.P., AH Parallel Fund V-B, L.P., and AH Parallel Fund V-Q, L.P. (collectively, the "AH Parallel Fund V Entities"). AH Equity Partners V (Parallel), L.L.C. ("AH EP V Parallel"), the general partner of the AH Parallel Fund V Entities, may be deemed to have sole voting and dispositive power over the securities held by the AH Parallel Fund V Entities. F8 · ownership.nature: (Continued from Footnote 7) Marc Andreessen and Benjamin Horowitz are the managing members of AH EP V Parallel and may be deemed to have shared voting and dispositive power over the securities held by the AH Parallel Fund V Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Parallel Fund V Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
December 17, 2021 Filed Dec 22, 2021 02:50 UTC	Samsara Inc. IOT · Entity 3218	ConversionSeries E Preferred Stock · Derivative	5,633,880	$0.00	$0.00	Disclosure SEC source: 0000899243-21-049321 · doc4.xml · derivative · entry 12 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By AH Parallel Fund V, L.P. Disclosed balance after: 0 Underlying: Class B Common Stock · 5,633,880 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F7 · ownership.nature: These securities are held of record by AH Parallel Fund V, L.P., for itself and as nominee for AH Parallel Fund V-A, L.P., AH Parallel Fund V-B, L.P., and AH Parallel Fund V-Q, L.P. (collectively, the "AH Parallel Fund V Entities"). AH Equity Partners V (Parallel), L.L.C. ("AH EP V Parallel"), the general partner of the AH Parallel Fund V Entities, may be deemed to have sole voting and dispositive power over the securities held by the AH Parallel Fund V Entities. F8 · ownership.nature: (Continued from Footnote 7) Marc Andreessen and Benjamin Horowitz are the managing members of AH EP V Parallel and may be deemed to have shared voting and dispositive power over the securities held by the AH Parallel Fund V Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Parallel Fund V Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
December 17, 2021 Filed Dec 22, 2021 02:50 UTC	Samsara Inc. IOT · Entity 3218	ConversionClass B Common Stock · Derivative	4,974,501	$0.00	$0.00	Disclosure SEC source: 0000899243-21-049321 · doc4.xml · derivative · entry 11 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By AH Parallel Fund IV, L.P. Disclosed balance after: 4,974,501 Underlying: Class A Common Stock · 4,974,501 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F5 · ownership.nature: These securities are held of record by AH Parallel Fund IV, L.P., for itself and as nominee for AH Parallel Fund IV-A, L.P., AH Parallel Fund IV-B, L.P., and AH Parallel Fund IV-Q, L.P. (collectively, the "AH Parallel Fund IV Entities"). AH Equity Partners IV (Parallel), L.L.C. ("AH EP IV Parallel"), the general partner of the AH Parallel Fund IV Entities, may be deemed to have sole voting and dispositive power over the securities held by the AH Parallel Fund IV Entities. F6 · ownership.nature: (Continued from Footnote 5) Marc Andreessen and Benjamin Horowitz are the managing members of AH EP IV Parallel and may be deemed to have shared voting and dispositive power over the securities held by the AH Parallel Fund IV Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Parallel Fund IV Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
December 17, 2021 Filed Dec 22, 2021 02:50 UTC	Samsara Inc. IOT · Entity 3218	ConversionSeries D Preferred Stock · Derivative	4,974,501	$0.00	$0.00	Disclosure SEC source: 0000899243-21-049321 · doc4.xml · derivative · entry 10 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By AH Parallel Fund IV, L.P. Disclosed balance after: 0 Underlying: Class B Common Stock · 4,974,501 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F5 · ownership.nature: These securities are held of record by AH Parallel Fund IV, L.P., for itself and as nominee for AH Parallel Fund IV-A, L.P., AH Parallel Fund IV-B, L.P., and AH Parallel Fund IV-Q, L.P. (collectively, the "AH Parallel Fund IV Entities"). AH Equity Partners IV (Parallel), L.L.C. ("AH EP IV Parallel"), the general partner of the AH Parallel Fund IV Entities, may be deemed to have sole voting and dispositive power over the securities held by the AH Parallel Fund IV Entities. F6 · ownership.nature: (Continued from Footnote 5) Marc Andreessen and Benjamin Horowitz are the managing members of AH EP IV Parallel and may be deemed to have shared voting and dispositive power over the securities held by the AH Parallel Fund IV Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Parallel Fund IV Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
December 17, 2021 Filed Dec 22, 2021 02:50 UTC	Samsara Inc. IOT · Entity 3218	ConversionClass B Common Stock · Derivative	4,313,218	$0.00	$0.00	Disclosure SEC source: 0000899243-21-049321 · doc4.xml · derivative · entry 9 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Andreessen Horowitz Fund IV, L.P. Disclosed balance after: 58,016,602 Underlying: Class A Common Stock · 4,313,218 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F4 · ownership.nature: These securities are held of record by Andreessen Horowitz Fund IV, L.P., for itself and as nominee for Andreessen Horowitz Fund IV-A, L.P., Andreessen Horowitz Fund IV-B, L.P., and Andreessen Horowitz Fund IV-Q, L.P. (collectively, the "AH Fund IV Entities"). AH Equity Partners IV, L.L.C. ("AH EP IV"), the general partner of the AH Fund IV Entities, may be deemed to have sole voting and dispositive power over the securities held by the AH Fund IV Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP IV and may be deemed to have shared voting and dispositive power over the securities held by the AH Fund IV Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Fund IV Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
December 17, 2021 Filed Dec 22, 2021 02:50 UTC	Samsara Inc. IOT · Entity 3218	ConversionSeries D Preferred Stock · Derivative	4,313,218	$0.00	$0.00	Disclosure SEC source: 0000899243-21-049321 · doc4.xml · derivative · entry 8 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Andreessen Horowitz Fund IV, L.P. Disclosed balance after: 0 Underlying: Class B Common Stock · 4,313,218 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F4 · ownership.nature: These securities are held of record by Andreessen Horowitz Fund IV, L.P., for itself and as nominee for Andreessen Horowitz Fund IV-A, L.P., Andreessen Horowitz Fund IV-B, L.P., and Andreessen Horowitz Fund IV-Q, L.P. (collectively, the "AH Fund IV Entities"). AH Equity Partners IV, L.L.C. ("AH EP IV"), the general partner of the AH Fund IV Entities, may be deemed to have sole voting and dispositive power over the securities held by the AH Fund IV Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP IV and may be deemed to have shared voting and dispositive power over the securities held by the AH Fund IV Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Fund IV Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
December 17, 2021 Filed Dec 22, 2021 02:50 UTC	Samsara Inc. IOT · Entity 3218	ConversionClass B Common Stock · Derivative	3,951,276	$0.00	$0.00	Disclosure SEC source: 0000899243-21-049321 · doc4.xml · derivative · entry 7 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Andreessen Horowitz Fund IV, L.P. Disclosed balance after: 53,703,384 Underlying: Class A Common Stock · 3,951,276 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F4 · ownership.nature: These securities are held of record by Andreessen Horowitz Fund IV, L.P., for itself and as nominee for Andreessen Horowitz Fund IV-A, L.P., Andreessen Horowitz Fund IV-B, L.P., and Andreessen Horowitz Fund IV-Q, L.P. (collectively, the "AH Fund IV Entities"). AH Equity Partners IV, L.L.C. ("AH EP IV"), the general partner of the AH Fund IV Entities, may be deemed to have sole voting and dispositive power over the securities held by the AH Fund IV Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP IV and may be deemed to have shared voting and dispositive power over the securities held by the AH Fund IV Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Fund IV Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
December 17, 2021 Filed Dec 22, 2021 02:50 UTC	Samsara Inc. IOT · Entity 3218	ConversionSeries C Preferred Stock · Derivative	3,951,276	$0.00	$0.00	Disclosure SEC source: 0000899243-21-049321 · doc4.xml · derivative · entry 6 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Andreessen Horowitz Fund IV, L.P. Disclosed balance after: 0 Underlying: Class B Common Stock · 3,951,276 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F4 · ownership.nature: These securities are held of record by Andreessen Horowitz Fund IV, L.P., for itself and as nominee for Andreessen Horowitz Fund IV-A, L.P., Andreessen Horowitz Fund IV-B, L.P., and Andreessen Horowitz Fund IV-Q, L.P. (collectively, the "AH Fund IV Entities"). AH Equity Partners IV, L.L.C. ("AH EP IV"), the general partner of the AH Fund IV Entities, may be deemed to have sole voting and dispositive power over the securities held by the AH Fund IV Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP IV and may be deemed to have shared voting and dispositive power over the securities held by the AH Fund IV Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Fund IV Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
December 17, 2021 Filed Dec 22, 2021 02:50 UTC	Samsara Inc. IOT · Entity 3218	ConversionClass B Common Stock · Derivative	9,259,278	$0.00	$0.00	Disclosure SEC source: 0000899243-21-049321 · doc4.xml · derivative · entry 5 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Andreessen Horowitz Fund IV, L.P. Disclosed balance after: 49,752,108 Underlying: Class A Common Stock · 9,259,278 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F4 · ownership.nature: These securities are held of record by Andreessen Horowitz Fund IV, L.P., for itself and as nominee for Andreessen Horowitz Fund IV-A, L.P., Andreessen Horowitz Fund IV-B, L.P., and Andreessen Horowitz Fund IV-Q, L.P. (collectively, the "AH Fund IV Entities"). AH Equity Partners IV, L.L.C. ("AH EP IV"), the general partner of the AH Fund IV Entities, may be deemed to have sole voting and dispositive power over the securities held by the AH Fund IV Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP IV and may be deemed to have shared voting and dispositive power over the securities held by the AH Fund IV Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Fund IV Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
December 17, 2021 Filed Dec 22, 2021 02:50 UTC	Samsara Inc. IOT · Entity 3218	ConversionSeries B Preferred Stock · Derivative	9,259,278	$0.00	$0.00	Disclosure SEC source: 0000899243-21-049321 · doc4.xml · derivative · entry 4 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Andreessen Horowitz Fund IV, L.P. Disclosed balance after: 0 Underlying: Class B Common Stock · 9,259,278 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F4 · ownership.nature: These securities are held of record by Andreessen Horowitz Fund IV, L.P., for itself and as nominee for Andreessen Horowitz Fund IV-A, L.P., Andreessen Horowitz Fund IV-B, L.P., and Andreessen Horowitz Fund IV-Q, L.P. (collectively, the "AH Fund IV Entities"). AH Equity Partners IV, L.L.C. ("AH EP IV"), the general partner of the AH Fund IV Entities, may be deemed to have sole voting and dispositive power over the securities held by the AH Fund IV Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP IV and may be deemed to have shared voting and dispositive power over the securities held by the AH Fund IV Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Fund IV Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
December 17, 2021 Filed Dec 22, 2021 02:50 UTC	Samsara Inc. IOT · Entity 3218	ConversionClass B Common Stock · Derivative	40,492,830	$0.00	$0.00	Disclosure SEC source: 0000899243-21-049321 · doc4.xml · derivative · entry 3 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Andreessen Horowitz Fund IV, L.P. Disclosed balance after: 40,492,830 Underlying: Class A Common Stock · 40,492,830 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F4 · ownership.nature: These securities are held of record by Andreessen Horowitz Fund IV, L.P., for itself and as nominee for Andreessen Horowitz Fund IV-A, L.P., Andreessen Horowitz Fund IV-B, L.P., and Andreessen Horowitz Fund IV-Q, L.P. (collectively, the "AH Fund IV Entities"). AH Equity Partners IV, L.L.C. ("AH EP IV"), the general partner of the AH Fund IV Entities, may be deemed to have sole voting and dispositive power over the securities held by the AH Fund IV Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP IV and may be deemed to have shared voting and dispositive power over the securities held by the AH Fund IV Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Fund IV Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
December 17, 2021 Filed Dec 22, 2021 02:50 UTC	Samsara Inc. IOT · Entity 3218	ConversionSeries A Preferred Stock · Derivative	40,492,830	$0.00	$0.00	Disclosure SEC source: 0000899243-21-049321 · doc4.xml · derivative · entry 2 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Andreessen Horowitz Fund IV, L.P. Disclosed balance after: 0 Underlying: Class B Common Stock · 40,492,830 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.exercise_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F3 · derivative.expiration_date: Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock and Series F Preferred Stock automatically converted into a share of Class B Common Stock on a 1:1 basis immediately prior to the completion of the Issuer's initial public offering of Class A Common Stock, and had no expiration date. The Class B Common Stock is convertible at any time, at the holder's election, into Class A Common Stock on a 1:1 basis, and has no expiration date. F4 · ownership.nature: These securities are held of record by Andreessen Horowitz Fund IV, L.P., for itself and as nominee for Andreessen Horowitz Fund IV-A, L.P., Andreessen Horowitz Fund IV-B, L.P., and Andreessen Horowitz Fund IV-Q, L.P. (collectively, the "AH Fund IV Entities"). AH Equity Partners IV, L.L.C. ("AH EP IV"), the general partner of the AH Fund IV Entities, may be deemed to have sole voting and dispositive power over the securities held by the AH Fund IV Entities. Marc Andreessen and Benjamin Horowitz are the managing members of AH EP IV and may be deemed to have shared voting and dispositive power over the securities held by the AH Fund IV Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH Fund IV Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
December 17, 2021 Filed Dec 22, 2021 02:50 UTC	Samsara Inc. IOT · Entity 3218	PurchaseClass A Common Stock	3,995,652	$23.00	$91,899,996.00	Disclosure SEC source: 0000899243-21-049321 · doc4.xml · nonDerivative · entry 1 Andreessen Horowitz Fund IV, L.P. · CIK 0001603198 · 10% owner Andreessen Horowitz Fund IV-A, L.P. · CIK 0001604853 · 10% owner Andreessen Horowitz Fund IV-B, L.P. · CIK 0001604855 · 10% owner Andreessen Horowitz Fund IV-Q, L.P. · CIK 0001604857 · 10% owner Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners IV, L.L.C. · CIK 0001603403 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By Andreessen Horowitz LSV Fund III, L.P. Disclosed balance after: 3,995,652 F1 · ownership.nature: In connection with the Issuer's initial public offering of Class A Common Stock, Andreessen Horowitz LSV Fund III, L.P. ("AH LSV Fund III"), for itself and as nominee for Andreessen Horowitz LSV Fund III-B, L.P. ("AH LSV Fund III-B") and AH 2022 Annual Fund, L.P. ("AH 2022 Annual" and together with AH LSV Fund III and AH LSV Fund III-B, the "AH LSV Fund III Entities"), purchased these shares of Class A Common Stock from the underwriters at the initial public offering price. AH Equity Partners LSV III, L.L.C. ("AH EP LSV III"), the general partner of AH LSV Fund III and AH LSV Fund III-B, may be deemed to have sole voting and dispositive power over the shares held by AH LSV Fund III and AH LSV Fund III-B. AH Equity Partners 2022 Annual Fund, L.L.C. ("AH EP 2022 Annual"), the general partner of AH 2022 Annual, may be deemed to have sole voting and dispositive power over the shares held by AH 2022 Annual. F2 · ownership.nature: (Continued from Footnote 1) Marc Andreessen and Benjamin Horowitz are the managing members of AH EP LSV III and AH EP 2022 Annual and may be deemed to have shared voting and dispositive power over the shares held by the AH LSV Fund III Entities. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by the AH LSV Fund III Entities and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
May 24, 2021 Filed May 25, 2021 12:08 UTC	Coinbase Global, Inc. COIN · Entity 480	SaleClass A Common Stock	100	$230.95	$23,095.00	Disclosure SEC source: 0001209191-21-035603 · doc4.xml · nonDerivative · entry 17 Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners III (Parallel), L.L.C. · CIK 0001540359 · 10% owner AH Capital Management, L.L.C. · CIK 0001540358 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By AH Capital Management, L.L.C. Disclosed balance after: 0 F15 · ownership.nature: The securities are held of record by AH Capital Management, L.L.C. The members of AH Capital Management, L.L.C. are Marc Andreessen and Ben Horowitz, who share voting and dispositive power with respect to the shares held by AH Capital Management, L.L.C. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by AH Capital Management, L.L.C. and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
May 24, 2021 Filed May 25, 2021 12:08 UTC	Coinbase Global, Inc. COIN · Entity 480	SaleClass A Common Stock	200	$229.73	$45,946.00	Disclosure SEC source: 0001209191-21-035603 · doc4.xml · nonDerivative · entry 16 Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners III (Parallel), L.L.C. · CIK 0001540359 · 10% owner AH Capital Management, L.L.C. · CIK 0001540358 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By AH Capital Management, L.L.C. Disclosed balance after: 100 F23 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $229.67 and the highest price at which shares were sold was $229.79. F15 · ownership.nature: The securities are held of record by AH Capital Management, L.L.C. The members of AH Capital Management, L.L.C. are Marc Andreessen and Ben Horowitz, who share voting and dispositive power with respect to the shares held by AH Capital Management, L.L.C. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by AH Capital Management, L.L.C. and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
May 24, 2021 Filed May 25, 2021 12:08 UTC	Coinbase Global, Inc. COIN · Entity 480	SaleClass A Common Stock	1,600	$228.88	$366,205.76	Disclosure SEC source: 0001209191-21-035603 · doc4.xml · nonDerivative · entry 15 Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners III (Parallel), L.L.C. · CIK 0001540359 · 10% owner AH Capital Management, L.L.C. · CIK 0001540358 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By AH Capital Management, L.L.C. Disclosed balance after: 300 F22 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $228.49 and the highest price at which shares were sold was $229.46. F15 · ownership.nature: The securities are held of record by AH Capital Management, L.L.C. The members of AH Capital Management, L.L.C. are Marc Andreessen and Ben Horowitz, who share voting and dispositive power with respect to the shares held by AH Capital Management, L.L.C. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by AH Capital Management, L.L.C. and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document
May 24, 2021 Filed May 25, 2021 12:08 UTC	Coinbase Global, Inc. COIN · Entity 480	SaleClass A Common Stock	1,201	$227.71	$273,484.51	Disclosure SEC source: 0001209191-21-035603 · doc4.xml · nonDerivative · entry 14 Andreessen Horowitz LSV Fund I, L.P. · CIK 0001772284 · 10% owner Andreessen Horowitz LSV Fund I-B, L.P. · CIK 0001772420 · 10% owner Andreessen Horowitz LSV Fund I-Q, L.P. · CIK 0001772407 · 10% owner AH Equity Partners LSV I, L.L.C. · CIK 0001772287 · 10% owner AH Equity Partners III (Parallel), L.L.C. · CIK 0001540359 · 10% owner AH Capital Management, L.L.C. · CIK 0001540358 · 10% owner HOROWITZ BENJAMIN A · CIK 0001166586 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · By AH Capital Management, L.L.C. Disclosed balance after: 1,900 F21 · price: Represents the weighted average sale price. The lowest price at which shares were sold was $227.35 and the highest price at which shares were sold was $228.05. F15 · ownership.nature: The securities are held of record by AH Capital Management, L.L.C. The members of AH Capital Management, L.L.C. are Marc Andreessen and Ben Horowitz, who share voting and dispositive power with respect to the shares held by AH Capital Management, L.L.C. Each of the Reporting Persons disclaims the existence of a "group" and disclaims beneficial ownership of the securities held by AH Capital Management, L.L.C. and this report shall not be deemed an admission that any such person is the beneficial owner of such securities, except to the extent of such person's pecuniary interest therein, if any. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.